Role of haem oxygenase in ischaemic preconditioning on the intestinal microcirculation following ischaemia reperfusion injury. by Mallick, I.H.
^Ehelfale of haem^ oxygenase in ischaemic 
preconditioning on the intestinal microcirculation 
4n-ischaemia reperfusion injury^of the intestine—  
Ismail Mallick MSc, MRCS
A thesis submitted for the Degree of Doctor of Philosophy 
University of London
Royal Free and University College Medical School, Hampstead Campus, 
University of London
London 2006UMI Number:  U592275
All rights reserved
INFORMATION TO ALL USERS 
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a complete manuscript 
and there are missing pages, these will be noted.  Also, if material had to be removed,
a note will indicate the deletion.
Dissertation Publishing
UMI U592275
Published by ProQuest LLC 2013.  Copyright in the Dissertation held by the Author.
Microform  Edition © ProQuest LLC.
All rights reserved.  This work is protected against 
unauthorized copying under Title  17, United States Code.
ProQuest LLC 
789 East Eisenhower Parkway 
P.O. Box 1346 
Ann Arbor, Ml  48106-1346DECLARATION CONCERNING THESIS PRESENTED FOR THE DEGREE OF
DOCTOR OF PHILOSOPHY 
I,  Ismail Hameed Mallick
of University Department of Surgery, Royal Free & University College Medical School, 
Hampstead Campus, Pond Street, London NW3 2QG
solemnly and sincerely declare, in relation to the thesis entitled:
The role of haeme oxygenase in ischaemic preconditioning on the intestinal 
microcirculation in ischaemia reperfusion injury of the intestine
(a)  That work was done by me personally
and (b) The material has not previously been accepted in whole, or in part, for any other 
degree or diploma.
Signature:  Date:
2Dedication
I have been very fortunate to have an extremely supportive family. I dedicate 
this thesis to my parents Shahul Hameed and Jamila, who built the foundations upon 
which I based my values and judgement. I also dedicate this thesis to my wife Femina 
and my two wonderful boys Faris and Tarik, while I thought I was taking care of them, 
they were taking care of me.
I also dedicate this thesis to my late friend and post-doctoral colleague Wenxuan 
Yang who offered his intellectual and personal support through out the course of my 
study and without whose help this thesis would not have been possible. I miss him a lot.
3Abstract
Intestinal ischaemia reperfusion (IR) injury is associated with various clinical 
conditions such as hypovolaemic shock, strangulation-obstruction, cardiovascular 
surgery, abdominal aortic surgery and small bowel transplantation. IR injury of the 
intestine is a systemic phenomenon resulting in bacterial translocation, endotoxaemia, 
acute respiratory distress syndrome and acute hepatic injury culminating in multiple 
organ failure.
It has been hypothesised that ischaemic preconditioning may protect against IR 
injury of the intestine through haem oxygenase formation. This thesis (study) 
investigated the relationship of haem oxygenase metabolism with intestinal 
microvascular perfusion, tissue oxygenation and function with ischaemic 
preconditioning of the intestine in an experimental model of ischaemia reperfusion 
injury of the small intestine.
Male Sprague Dawley rats (250-300 grams) were subjected to 30 mins of 
ischaemia by clamping of superior mesenteric artery followed by 2 hrs (early phase) or 
24 hrs (late phase) of reperfusion. Ischaemic preconditioning was performed with  10 
min ischaemia and 10 min reperfusion before the sustained ischaemia. Pyrrolidine 
dithiocarbamate (PDTC) or Zinc Protoporrphyrrin (ZnPP) were administered to 
stimulate or block heme oxygenase synthesis. The study demonstrated that ischaemic 
preconditioning resulted in significantly improvement in intestinal microvascular 
perfusion, tissue oxygenation as well as decreased leukocyte-endothelial interactions 
and intestinal and pulmonary injury following both early and late phases of IR injury.
4The preconditioning effect was associated with significantly increased haem oxygenase 
production suggested by intestinal tissue haeme oxygenase levels as demonstrated by 
haem oxygenase assays and western blotting. PDTC treatment reproduced the protective 
effect of ischaemic preconditioning. Haem oxygenase inhibition with ZnPP antagonized 
the protective effect of ischaemic preconditioning.
This thesis has shown that the protective effect of intestinal ischaemic 
preconditioning against both early and late phases of IR injury is associated with 
increased haem oxygenase production. These data may have important implications in 
intestinal surgery and transplantation and may lead to the development of 
pharmacological strategies for protecting the intestine from ischaemic injury.
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16Chapter 1 Literature review: The role of Microcirculation in 
Ischaemia Reperfusion Injury of the Intestine
171.1  Anatomical and Physiological Considerations
The entire gastrointestinal system is supplied by three direct branches of the 
aorta: the coeliac artery, the superior mesenteric artery, and the inferior mesenteric 
artery (Geboes et al., 2001). The coeliac artery supplies blood flow to the stomach, 
liver, and spleen, while the superior mesenteric artery, the largest single branch of the 
abdominal aorta, supplies the entire small intestine, proximal portions of the large 
intestine and the pancreas. The inferior mesenteric artery supplies blood flow to the 
distal portion of the large intestine(Geboes et al., 2001).
The small intestine is composed of three layers namely, the mucosa, submucosa 
and muscularis. Each of the major functions of the small intestine- absorption, secretion 
and motility is mainly localised to one of the three layers. Absorption is subserved by 
the large surface area created by the architecture of the mucosa with its abundance of 
villi and microvilli. The secretory function is mainly localised to the submucosa and 
basal region of the mucosa i.e. in the glands located at the base of the villi and lining the 
crypts. Lastly, the intestinal movements, both propulsive and non-propulsive are 
dependent on the contraction and relaxation of the longitudinal and circular smooth 
muscles of the muscularis(Granger et al.,  1980).
The superior mesenteric artery divides into arcade branches which supply the 
intestine through the mesentery. They enter the serosa and arborize into several 
branches. Some of these branches converge in the anti-mesenteric border where many 
anastomoses are formed. In their course towards the anti-mesenteric border these blood 
vessels give rise to numerous branches that form the mural trunks of the serosa. From 
each villus, one or more vessels are formed which course outward from the villus to
18eventually joins the veins of the glandular region before entering the submucosa where 
they merge with the veins draining the submucosal plexus. These vessels continue on 
through the muscularis layer and serosa, and then merge with other vessels, before 
draining into the portal vein via the superior mesenteric vein (Lanciault and Jacobson, 
1976). Blood flow to the mucosa-submucosal layer normally accounts for 80% of the 
total intestinal flow. The high proportion of blood flow to the mucosa-submucosa 
presumably reflects the higher metabolic demand in these layers of the small intestine 
(Bohlen, 1998).
The term ‘microcirculation’ refers to the vascular network and includes the 
resistance vessels, the pre-capillary sphincters, the true capillaries, the post-capillary 
sphincters and the venulae with the flow of blood through this network (Uhlmann et al., 
1999). The resistance vessels of the intestine regulate the arterial blood inflow pressure 
to the intestine and the proportion of the cardiac output. The pre and the post-capillary 
sphincters regulate the mean hydrostatic capillary pressure, a variable which is crucial 
in the determination of the direction and the magnitude of net movement of fluid across 
the capillary. The pre-capillary sphincter determines the number of capillaries that are 
open at a time point. The vascular bed of the intestine reduces its vascular resistance to 
blood flow following a decrease in perfusion pressure. This autoregulation of blood 
flow is effective over a wide pressure range. Autoregulation is described as an intrinsic 
ability of an organ to maintain a constant blood flow in the face of a fluctuating arterial 
pressure (Johnson,  1960). The site of autoregulation in the intestine has been localised 
to the pre-capillary resistance vessels. As the perfusion pressure falls, flow is 
redistributed among the various layers of the intestine, with an increase in flow to the 
more metabolically active superficial mucosa.
19The intestinal microcirculation has unique characteristic features that are 
essential in the understanding of the intestinal reaction to ischaemia. The intestinal 
vascular bed has a high capillary density and high capillary permeability than other 
vascular circuits, excluding the hepatic sinusoids. The venous blood pressure and mean 
hydrostatic capillary pressure is higher in the intestine than other vascular beds. Hence, 
the intestinal vascular bed is a risk of losing considerable amount of fluids when the 
capillary pressure becomes elevated. The homeostatic mechanisms aim to maintain 
these pressures constant. These delicate mechanisms may be altered in ischaemia 
reperfusion (IR) injury of the intestine.
1.2  Intestinal Ischaemia Reperfusion Injury
Ischaemia reperfusion (IR) injury of the intestine is an important factor associated 
with a high morbidity and mortality in both surgical and trauma patients (Koike et al., 
1993). It is of importance in situations such as the interruption of blood flow to the gut 
as in abdominal aortic aneurysm surgery, cardiopulmonary bypass, strangulated hernias, 
neonatal necrotising enterocolitis and intestinal transplantation (Collard and Gelman, 
2001). IR injury also occurs in septic and hypovolemic shock (Moore et al.,
1994;Swank and Deitch,  1996).
Interruption of blood supply results in ischemic injury which rapidly damages 
metabolically active tissues. Paradoxically, restoration of blood flow to the ischemic 
tissue initiates a cascade of events that may lead to additional cell injury known as 
reperfusion injury. This reperfusion damage frequently exceeds the original ischemic 
insult (Stallion et al., 2002). On restoration of the blood supply, the molecular and
20biochemical changes that occur during ischaemia predispose to free radical mediated 
damage. The reduction of blood supply results in damage of the intestinal mucosa.
Among the internal organs, the intestine is probably the most sensitive to IR injury 
(Granger et al.,  1986;Yamamoto et al., 2001). The intestine is composed of labile cells 
that are easily injured by episodes of ischaemia. Subsequent reperfusion of the intestine 
results in further damage of the mucosa (Kong et al.,  1998). It has been shown that the 
enterocytes that are located at the tips of the villi are more sensitive to the effect of 
ischaemia. This was attributed to their location at the end distribution of a central 
arteriole which leads to lower oxygen tension compared to the crypt (Kong et al., 
1998;Takeyoshi et al., 1996). However a recent study in a rat model demonstrated that 
the sensitivity of an enterocyte is dependent on the state of its differentiation 
(Hinnebusch et al., 2002).
There is substantial evidence that the mucosa of the intestine becomes the site for the 
production of various acute-phase proteins (Molmenti et al.,  1993;Wang et al.,  1998), 
gut hormones (Zamir et al.,  1992)and cytokines (Mester et al.,  1993;Meyer et al., 
1995).These influence not only the intestine but may also effect the function and 
integrity of distant organs. The initial site of abnormality in ischaemia has been 
emphasised on the cellular mitochondria, which is particularly important in producing 
adenosine triphosphate (ATP) for organ recovery (Jassem et al., 2002). The damage, 
however, is dramatically magnified by a large number of events, such as oxygen free 
radical formation, release of iron storage, damage of the microvasculature of IR organs, 
inflammatory cytokines, complement activation and neutrophil infiltration at the site of 
injury (Carden and Granger, 2000). The enterocyte, in particular has been shown to
21produce increased amounts of cytokines during sepsis, endotoxemia, hemorrhagic shock 
and trauma (Ogle et al.,  1994).
1.3  Consequences of Intestinal Ischaemia Reperfusion Injury
1.3.1 Alteration of absorptive function of intestine
Several studies have demonstrated an alteration of absorptive function of the 
intestine following IR injury of the intestine (Kuenzler et al., 2002b;Prasad et al., 
2001;Rajeevprasad et al., 2000). This could lead to deficient absorption of nutrients. In 
severe cases such as infarction of the bowel, short-bowel syndrome can occur (Scolapio 
and Fleming, 1998). Sileri et al. demonstrated in a rat model that IR injury of the 
intestine causes both acute and chronic alterations of the intestinal absorptive function, 
which was associated with significant mortality (Sileri et al., 2002).
1.3.2 Bacterial translocation
Bacterial translocation is the passage of viable bacteria from the gastrointestinal tract 
through the epithelial mucosa to the extraintestinal sites such as mesenteric lymph 
nodes, liver and spleen (Van Leeuwen et al.,  1994). Subsequently the bacteria can 
disseminate throughout the body producing sepsis, shock or multiple organ failure 
(MOF). Bacterial translocation has been reported to occur in 44% of paediatric patients 
undergoing small bowel transplantation (Cicalese et al., 2001). The increase in 
intestinal hyperpermeabilty occurring in IR injury of the intestine is one of the factors 
causing bacterial translocation (Aksoyek et al., 2002;Iijima et al.,  1997;Xia et al., 2002) 
. The other factors are overgrowth of bacteria in the small intestine and differences in 
host immune defences (Berg, 1999).
221.3.3  Injury to distant organs
IR injury to the intestine results in production of molecules such as hydrogen peroxide, 
superoxide and inflammatory cytokines that may harm distant organs. This leads to the 
development of Systemic Inflammatory Response Syndrome (SIRS) which can progress 
to MOF (Ceppa et al., 2003). Intestinal IR injury also causes pulmonary infiltration of 
neutrophils, which contributes to the development of acute respiratory distress 
syndrome (ARDS) (Koksoy et al., 2001;Xiao et al.,  1997). Hence, the gut has been 
referred to as ‘the motor of MOF’ (Marshall,  1998).
1.4  Mediators Involved in IRI of the Intestine
1.4.1  Xanthine oxidase & oxygen free radicals
Xanthine oxidase (XO) is a highly versatile enzyme which plays an important role in 
the catabolism of purines. The intestine is the richest source which is the initial source 
of free radicals that can cause further tissue damage (Parks et al.,  1988). In mammals 
xanthine dehydrogenase (XDH) can be converted to XO either reversibly or irreversibly 
(Meneshian and Bulkley, 2002). During the ischemic period, cellular ATP is catabolised 
to yield hypoxanthine (Younes et al.,  1984). The hypoxic stress also triggers the 
conversion of XDH to the oxygen radical-producing XO. ATP depletion results in loss 
of ATP-dependent ion channel regulation, producing passive ion shifts across cell 
membranes: K+ and Mg ++ diffuse out, but Na+, Ca++ and H2O diffuse in causing cell 
swelling. Increased cellular Ca++ is harmful, one of its important consequences being the 
activation of a calcium-dependent protease, which cleaves XDH to XO. During 
reperfusion, molecular oxygen is re-introduced into the tissue where it reacts with 
hypoxanthine and XO to produce a burst of oxygen free radicals- superoxide anion 
(O2") and hydrogen peroxide (H2O2) (Harrison, 2002) (Fig  1.1).
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Figure 1.1. Mechanism of xanthine oxidase mediated free radical injury. 
Modified from Granger (Granger et. al,  1986)
24Under physiological conditions, the damaging effects of O2 "are prevented by 
superoxide dismutase (SOD), which converts 0 2 " to H2O2  (Harrison, 2002). However, 
during reperfusion of ischemic tissues, these natural defenses may be overcome. C > 2~ 
itself is a relatively low energy radical, but it is responsible for production of the highly 
reactive and damaging hydroxyl radical (OH*) .Typically the OH* causes biological 
damage by stimulating the free chain reaction known as lipid peroxidation, in which 
OH* attacks the fatty acid side chains of the membrane phospholipids and causes 
organelle and cell disruption (Halliwell and Gutteridge,  1999).
1.4.2 Endothelins
Endothelins (ETs) are potent peptide vasoconstictors derived from the vascular 
endothelium (Ozel et al., 2001). Among the three active isoforms (ET-1, ET-2 and ET- 
3), ET-1 is the most powerful endogenous vasoconstrictor substance known to date 
(Inoue et al.,  1989;Yanagisawa et al., 1988).The vasoconstrictive effects of ET-1 are 
predominantly mediated via ET-A receptors present on vascular smooth muscle cells 
.The ET-B receptors mediate vasoconstriction (ET-B2) and vasodilatation (ET-Bj) 
(Clozel et al., 1992). ET receptor antagonists provide significant protection against IR 
injury of the intestine (Anadol et al.,  1998;Andrasi et al., 2002;Buyukgebiz et al., 
1994;Oktar et al., 2002;Wolfard et al., 2002). The major beneficial effects of ET 
inhibition include a decrease in mucosal lesions, an increase in blood flow, an increase 
in mucosal ATP and a decrease in leukocyte adhesion (Oktar et al., 2000).
1.4.3 Heat shock proteins
Heat Shock Proteins (HSP) are intracellular stress proteins that have been shown to 
accumulate after ischaemia (Tsuruma et al.,  1996b).The concept of sub-lethal whole 
body hyperthermia conferring tolerance to ischaemia and endotoxin exposure is known
25as hyperthermic preconditioning and has been associated with HSP accumulation 
(Hotchkiss et al., 1993;Ryan et al., 1992). In the rat intestine, tolerance to ischemic 
injury has been associated with the production of various inducible HSP: HSP-70 
(Fleming et al., 2002), HSP-72 (Stojadinovic et al.,  1995) and HSP-73 (Tsuruma et al.,
1999). The exact mechanism whereby HSPs confer protection of the intestine against IR 
injury is not known. Stojadinovic and co-workers showed that a probable mechanism 
involves the inhibition of leukotriene-B4 production and subsequent prevention of 
neutrophilic activation and chemotaxis (Stojadinovic et al.,  1995).
1.4.4  Polymorphonuclear neutrophils (PMN)
There is a growing body of evidence that incriminates PMNs in the pathophysiology of 
IR injury (Hayward and Lefer,  1998;Hierholzer et al.,  1999;Cooper et al., 2004;Mbachu 
et al., 2004). In a model of small bowel transplantation, Massberg et al showed the 
manifestation of IR injury is primarily due to the leukocyte-endothelial cell interactions 
in the submucosal venules of the transplanted intestine (Massberg et al.,  1998).
PMNs depleted blood in the reperfusate has been shown to ameliorate IR injury in 
the human small bowel (Sisley et al.,  1994). Intravital microscopic studies of tissues 
exposed to IR injury reveal an acute inflammatory response that is characterised by 
increased adhesion and emigration of PMNs in post capillary venules and enhanced 
protein efflux (Granger and Korthuis,  1995). Indirectly, the assessment of neutrophil 
migration into the small intestine is performed by measuring myeloperoxidase (MPO) 
activity in the small intestine(Naito et al., 2002).
The emigration of PMNs from the post capillary venules to areas of inflammation is 
a complex and a highly coordinated three-step process namely rolling, adhesion and 
extravasation (Grisham et al.,  1998)(Fig 1.2).
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Figure 1.2.  Sequence of events in emigration of neutrophils.
First, the endothelial Selectins are upregulated and interact with the oligosaccharides on 
the  surface  of  leukocytes.  This  then  brings  the  leukocyte  into  close  proximity  of 
chemoattractants  such  as  chemokines  which  then  activates  the  integrins.  Integrins 
(CD11/CD18) binds to the endothelial receptors (ICAM-1) resulting in strong adhesion 
followed  by  extravasation  of  the  neutrophils.  Reproduced  from  Collard  and 
Gelman(Collard and Gelman, 2001).
27First the leukocytes roll along the endothelial cell surface. This initial reaction is 
mediated by the upregulation of adhesion molecules such as P-selectin and E-selectin 
on the surface of the endothelium and their interaction with L-selectin which is 
expressed constitutively by the leukocytes. This weak leukocyte tethering to the 
endothelium brings the leukocyte into close proximity of chemoattractants (e.g., 
leukotriene B4, C5a and PAF) and chemokines (Granger,  1988). Chemokines bind to 
receptors on leukocytes to activate P2 integrins (CD1 la, CD1 lb and CD 11 c/CD 18).
The activated integrins bind to the adhesion molecules such as the intercellular adhesion 
molecule (ICAM-1) or the vascular cellular adhesion molecule (VCAM-1) expressed on 
the endothelial cells. This interaction strengthens the adhesion between the leukocyte 
and the endothelial cells, thereby allowing extravasation of the leukocyte out of the 
circulation into the interstitium (Panes et al.,  1999). Riaz et al. showed that following 
IR injury of the mouse intestine, both P&E selectins were expressed (Riaz et al.,
2002a). Pre-treatment with anti-P selectin antibody reduced PMNs rolling and adhesion, 
thereby attenuating the injury (Riaz et al., 2002a). PMNs can cause tissue damage by 
several ways including secretion of proteolytic enzymes such as elastase from 
cytoplasmic granules (Carden et al.,  1990), production of free radicals via the 
respiratory burst (Weiss,  1989) and by physical impairment of the microcirculation and 
thereby extension of ischaemia (Bagge et al.,  1980). Nalini and colleagues showed that 
it is the PMNs and not XO that are the initial source of free radicals in a rat model of IR 
injury of the intestine (Nalini et al.,  1993).
1.4.5  Nitric Oxide (NO)
NO is a free radical and a highly reactive substance. NO is synthesised from L-arginine 
by a family of enzymes known as NO synthases (NOS). Three isoforms of NOS have 
identified and cloned namely: endothelial NOS (eNOS), neuronal NOS (nNOS) and
28inducible NOS (iNOS) (Albrecht et al., 2003). Whereas eNOS and nNOS are 
constitutively expressed, iNOS is only expressed in response to cytokines and growth 
factors. nNOS is the predominant NOS in the normal intestine and this suppresses the 
expression of iNOS (Qu et al., 2001). The possible sources of NO in the intestine 
include intrinsic intestinal tissue (epithelium, mast cells, smooth muscle and neural 
plexus) and the leukocytes (PMNs and monocytes) (Salzman,  1995).
The role of NO in IR injury is still a matter of considerable controversy. NO 
plays a dichotomous role both as a cytotoxic and cytoprotective molecule in intestinal 
IR injury. Whereas, inhibition of NO causes tissue dysfunction in certain models of IR 
injury, inhibition of NO provides benefit in others. The constitutive forms of NO 
synthase (nNOS and eNOS) are critical to normal physiology and inhibition of these 
enzymes cause tissue damage (Kubes and McCafferty, 2000). The induction of iNOS 
produce large amounts of NO and peroxynitrite leading to tissue injury and therefore 
specific inhibition of this enzyme is considered beneficial (Kubes and McCafferty,
2000). Additionally, iNOS knockout mice exhibited significant resistance to mucosal 
barrier dysfunction and bacterial translocation after intestinal IR injury, further 
supporting a role for iNOS as an important mediator of reperfusion injury in the 
intestine (Suzuki et al., 2000). On the contrary, Cuzzocrea et al provided evidence that 
the production of peroxynitrate was not related to the induction of iNOS, whereas it was 
associated with the inhibition of eNOS (Cuzzocrea et al.,  1998).  In a recent study, Wu 
et al. demonstrated that the formation of iNOS after IRI of the intestine enhanced 
mucosal apoptosis leading to IR injury of the intestine (Wu et al., 2002). Virlos et al 
showed that pulmonary injury following intestinal IR injury was associated with 
decreased eNOS expression in the lung (Virlos et al., 2003). Expression of iNOS 
occurred during the later stages of reperfusion, with overproduction of NO and
29nitrosylation of protein tyrosine residues, thus aggravating pulmonary injury(Virlos et 
al, 2003).
NO has many beneficial effects in the intestine such as scavenging of oxygen free 
radicals, maintenance of normal vascular permeability, inhibition of smooth muscle 
proliferation, reduction of leukocyte adherence to the mesenteric endothelium, 
prevention of mast cell activation and inhibition of platelet aggregation (Wink et al., 
1993;Kosonen et al.,  1999;Gidday et al.,  1998;Guo et al.,  1996;Lefer and Lefer,  1996).
Under physiological conditions, NO will predominate in the microcirculation 
(Wink and Mitchell, 1998). However during the early phase of reperfusion in IR injury 
there is accumulation of O2-. This would limit the accumulation of NO and prevent any 
of its beneficial effects. Hence there is a tendency for the PMNs to adhere to the 
endothelium and for the platelets to aggregate (Gauthier et al.,  1994).In the absence of 
NO, the O2'  produced will undergo spontaneous dismutation to form H2O2. The H2O2 
formed in this way can promote the activation of Phospholipase A2 (PLA2) and leads to 
the accumulation of pro-inflammatory mediators such as platelet activating factor (PAF) 
and leukotrienes (LTB4) (Summarised in Fig  1.3). These factors can lead to activation 
of transcription factor nuclear factor kappa B (NF-kB) which is a primary regulator of 
cytokine and adhesion molecule gene expression. Thus, the loss of endogenous NO 
production has disastrous consequences resulting in dysfunction of the endothelium and 
PMNs mediated tissue injury.
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Figure 1.3. Role of nitric oxide in ischaemia -  reperfusion injury.
311.4.6  Haem Oxygenase
HO-1 expression in various models of IR injury of the intestine has shown to offer 
cytoprotection during the cascade of events in D R . injury (Ito et al, 2003;Attuwaybi et 
al., 2004;Nakao et al., 2003;Squiers et al.,  1999).  HO-1 is the rate-limiting enzyme in 
the conversion of heme into carbon monoxide (CO), biliverdin (which is rapidly 
converted to bilirubin) and free iron (Fe2+) (Choi and Alam,  1996). The HO-1  system is 
thought to play a pivotal role in the maintenance of antioxidant and oxidant homeostasis 
during cellular injury (Katori et al., 2002b). Three isoforms of HO have so far been 
identified: inducible HO-1; constitutively expressed HO-2 and HO-3 which is related to 
HO-2, but is less well characterized. The HO-1 system exerts four major beneficial 
effects broadly: (a) antioxidant function; (b) maintenance of the microcirculation; (c) 
anti-apoptosis and (d) anti-inflammatory function (Katori et al., 2002b). The antioxidant 
function relies on heme degradation, production of bilirubin (Stocker et al.,  1987) and 
the formation of ferritin via Fe2+ (Balia et al.,  1992). The production of CO with its 
vasodilatory and anti-platelet properties maintains the microcirculation and may be 
involved in the anti-apoptotic and cell arrest mechanisms (Katori et al., 2002b). The 
HO-1  system exerts anti-inflammatory effects via modulation of endothelial adhesion 
molecules and chemoattractant factors (Willis et al.,  1996). Vachharajani et al provided 
evidence that HO-1 and biliverdin modulate leukocyte recruitment by altering the 
expression of P and E-selectins in the intestine, lungs, liver and kidneys (Vachharajani 
et al., 2000). It has also been shown that HO-1 inhibits the NO system by 
downregulating iNOS, which contains a heme-iron moiety (Coito et al., 2002).
Nakao et al showed that inhalation of CO improved graft function and survival in a rat 
model of small bowel transplantation (Nakao et al., 2003). Exogenous administration of 
bilirubin has shown to reduce intestinal injury in rat models of IR injury (Ceran et al.,
322001;Hammerman et al., 2002). Doxorubicin has been shown to induce HO-1 and 
attenuate lung injury following IRI of the intestine (Ito et al., 2003). Squiers et al have 
shown that HO-1  overexpression in small bowel donors may decrease IR injury and 
improve survival of both the animal and the transplanted bowel (Squiers et al.,  1999). 
Recently Attuwaybi et al demonstrated that subcutaneous administration of hemin (HO- 
1  inducer) significantly reduced IR injury of the intestine (Attuwaybi et al., 2004).
1.4.7  Pro-inflammatory Proteins
The precise chemical steps connecting the generation of free radicals and secretion of 
inflammatory mediators by the endothelial cells are not well understood. It appears that 
NO is a key factor involved in the synthesis of pro-inflammatory proteins (Anaya-Prado 
et al., 2002).NO may be exerting its effects at the transcription level probably by the 
regulation of NF-kB which regulates the expression of several genes that are involved in 
the process of IRI (Zingarelli et al., 2003)(Fig 1.4). NF- kB belongs to a family of 
dimeric transcription factor complexes which is normally found in the cytoplasm of 
unstimulated cells in their inactive forms i.e., as the p50/p65/I- kB ternary complex or 
the p65/pl05 inactive binary complex. Stimulation of cells with certain cytokines, 
oxidants or inflammatory mediators such as PAF or LTB4 results in phosphorylation 
and ubiquitination of the I- kB or p i05 subunit (Siebenlist et al.,  1994;Collins et al.,
1995). This results in translocation of the subunit to the nucleus to activate transcription 
of its target genes. NF- k;B induces the expression of adhesion molecules (ICAM-1, 
VCAM-1, P-selectin, E-selectin), tumour necrosis factor (TNF- a and P), interleukins, 
chemokines and enzymes (inducible nitric oxide synthase and cyclooxygenase-2 ) 
(Barnes,  1997;Blackwell and Christman,  1997).  It appears that in IR injury, 
reoxygenation is the key stimulus in the regulation of NF-kB .By maintaining the 
interaction between IkBoi and NF-kB, upregulation of adhesion molecules is inhibited
33(Spiecker et al., 1998). NO appears to prevent the formation of substances that activate 
NF-kB as well as enhance the activity of proteins that inhibit NF-kB. Previous studies 
suggest that NO may induce the denovo synthesis or stabilise IkBoi, thereby limiting 
NF-kB activation (Peng et al.,  1995).
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Figure 1.4.  The relationship between oxidants and activation of NF-kB.
The  transcription  factor NF-kB  is  normally  found  in  the  cytoplasm of the  cell  in  an 
inactive form as p50/p65/ I- kB complex. Upon stimulation of the cells with cytokines, 
oxidants or bacterial products leads to an increase in reactive oxygen metabolites, which 
then activates I- kB kinase. This kinase phosphorylates the inhibitory complex, which is 
then  ubiquitinated.  Following  which  proteolysis  occurs  by  the  action  of  the  26S 
proteasome complex and nuclear translocation of the active NF-kB.
351.4.8 Complement
Several studies have suggested that the complement system is a major candidate in the 
pathogenesis of IR injury of the intestine (Austen Jr et al., 2003;Heller et al., 
1999;Kimura et al.,  1998;Wada et al., 2001).P-selectin has been shown to mediate IR 
injury of the intestine via complement(C5b-9) deposition in the intestinal mucosa 
(Gibbs et al.,  1996). Activation of the complement cascade leads to a series of potent 
inflammatory events including the expression of ICAM-1  gene and the up-regulation of 
cytokines such as TNF-a and interleukin (IL-1 a) (Wada et al., 2001).In a recent study it 
has been shown by Montalto et al. that complement mediates up-regulation of intestinal 
iNOS and diminishes protein levels of mitochondrial SOD  and the activity of Cu/Zn 
SOD (Montalto et al., 2003).
1.4.9 Iron
During ischaemia, metabolites such as lactic acid accumulate and the intracellular pH 
falls. This decreases the stability of lysosomal membranes, activates lysosomal lytic 
enzymes, inhibits the binding of transitional metals such as iron to their carrier proteins 
(e.g. transferrin and ferritin) and results in increased free intracellular iron (Fe2+) , which 
accelerates in vivo free radical formation in the following (Haber -  Weiss) reaction:
Fe2+ + H2O2 — >  Fe3+ + OH' + H* (Hernandez et al.,  1987).Using chelating agents of iron 
such as desferrioxamine has proved to be effective in reducing IRI because these agents 
prevent the Haber - Weiss reaction and hydroxyl radical formation (Lelli, Jr. et al.,
1993).
361.5  Protective Strategies against Ischaemia-Reperfusion Injury of the 
Intestine
The mechanisms of IR injury of the intestine and the ways to limit these have been 
under extensive research for almost a decade. Several therapeutic modalities have been 
successfully used to attenuate reperfusion injury in animal models of IR injury of the 
intestine. Potential strategies to overcome IR injury include several modalities: (a) 
ischaemic preconditioning (IPC); (b) antioxidants; (c) NO supplementation; (d) Anti­
complement therapy; (e) anti-leukocyte therapy; (f) perfluorocarbons, (g) enteral 
feeding; (h) glutamine supplementation; and (i) glycine supplementation.
1.5.1  Ischaemic Preconditioning (IPC)
IPC refers to a phenomenon whereby exposure of a tissue to brief periods of ischaemia 
protects them from the deleterious effects of prolonged IR injury (Richard et al.,  1994). 
This fascinating phenomenon was first described in  1986 by Murry et al. in the heart of 
canines (Murry et al.,  1986). Subsequently beneficial effects have been demonstrated in 
the liver (Koti et al., 2002a), skeletal muscle (Pang et al,  1997), brain (Glazier et al.,
1994), spinal cord (Sakurai et al.,  1998), kidney (Turman and Bates,  1997), lung (Du et 
al.,  1996),  retina  (Li  et  al.,  2003)  and  intestine  (Sola  et  al.,  2001;Davis  et  al., 
1999;Vlasov  et  al.,  2002;Aksoyek  et  al.,  2002)  in  various  animal  models.  There  is 
compelling evidence that IPC is beneficial in the human heart (Jenkins et al.,  1997) and 
the liver (Clavien et al., 2003).
IPC of the intestine was first described by Hotter et al. in 1996 (Hotter et al.,
1996)  and subsequent studies have confirmed this phenomenon (Tablel.l). During this 
procedure, the small bowel is rendered ischaemic by placing an occlusion vascular 
clamp around the superior mesenteric artery. After an ischaemic interval of 5-20 
minutes, the clamp is removed and the small intestine is reperfused for 5-15 minutes,
37before the prolonged ischaemic insult. However, the ideal IPC protocol including the 
time of short ischaemia and number of cycle(s) is still not established. Some studies 
have reported that more than one cycle of ischaemia and reperfusion is required to 
achieve this beneficial effect (Unal et al., 2003;McCallion et al., 2000).
38Table 1.1 A list of studies in which ischaemic preconditioning was performed against 
reperfusion injury in the intestine.
Author Species IPC Protocol Mechanism Outcome
Aksoyek S 
(Aksoyek et al., 
2002)
Rats 10 mins of ischaemia &  10 mins of 
reperfusion
|iNOS expression itissue damage & bacterial transloc;
Cinel KCinel et 
al, 2003)
Rats 10 mins of ischaemia anti-apoptosis jnumber of apoptotic cells
Ferencz A 
(Ferencz et al., 
2002)
Dogs 4 cycles of 5 mins ischaemia &  10 
mins of reperfusion
oxidative stress TGSH & SOD
McCallion K 
(McCallion et al., 
2000)
Rats 3 cycles of 2 min ischaemia & 5 
min of reperfusion
| adenosine protects against mucosal barrier 
dysfunction
Sola A(Sola et 
al., 2001)
Rats 10 mins of ischaemia & 5 mins of 
reperfusion
fNO synthesis itissue damage in this model of 
intestinal transplantation
Tamion F 
(Tamion et al, 
2002)
Rats 4 cycles of lmin ischaemia &  10 
mins of reperfusion
expression of HO-1 | fluid requirements, J , pulmonary 
oedema, |lactate & TNF-a
Unal S(Unal et 
al, 2003)
Rats 2 cycles of 5 min ischaemia & 5 
min reperfusion
|neutrophil infiltration, 
j oxidative stress and anti- 
apoptotic
J.MDA, jMPO, J,tissue damage
Vlasov
TD(Vlasov et a l, 
2002)
Rats 10 mins of ischaemia &  10 mins of 
reperfusion
|NO synthesis itissue damage
Wu B(Wu et al, 
2004)
Rats 20 mins of ischaemia & 5 mins of 
reperfusion
anti-apoptosis jreactive oxygen species, |lipid 
peroxidation, jcytochrome c &|casj 
6
39GSH, glutathione; HO-1, haem oxygenase-1; iNOS, inducible nitric oxide synthase; 
MDA*, malonyldialdehyde; MPO, myloperoxidase; NO, Nitric Oxide; SOD, 
superoxide dismutase.
40The effects of IPC can be differentiated into two phases characterized by different time 
frames and mechanisms: (a) an early phase (early or classic preconditioning) that 
immediately follows the transient ischaemia and lasts 2-3 hours and (2) a late phase 
(late preconditioning), which begins  12-24 hours from the transient ischaemia and lasts 
for about 3-4 days (Cohen et al., 2000;Bolli, 2000;Yellon and Dana, 2000) .Whereas 
early IPC occurs within minutes and involves the direct modulation of specific cell 
functions (Cohen et al., 2000), the late phase requires the simultaneous activation of 
multiple stress-response genes with de novo synthesis of several proteins (Bolli, 2000). 
Despite these differences, both phases of preconditioning can be initiated by the same 
stimuli and share the same intracellular signal pathways to a certain extent (Bolli, 2000). 
Because of its sustained duration, late preconditioning might be particularly relevant for 
improving the results of small bowel transplantation. However, the present knowledge 
of the mechanisms responsible is quite preliminary. Recently, Ferencz et al. 
demonstrated that synthesis of proteins such as SOD and GSH was instrumental in the 
protection afforded by delayed IPC in a canine model of small bowel 
autotransplantation (Ferencz et al., 2004).
The  exact  mechanism  by  which  IPC  confers  protection  in  the  intestine  is  unclear. 
Several  mediators  have  been  advocated  to  play  a  crucial  role  in  this  protective 
phenomenon including adenosine (Unal et al., 2003;McCallion et al., 2000), NO (Sola 
et al., 2001), oxidative stress (Ferencz et al., 2002), heme oxygenase  1   (HO-l)(Tamion 
et al., 2002) and anti-apoptosis (Wu et al., 2004).
Aksoyek  et  al.  showed  that  IPC  of  the  intestine  decreases  the  translocation  of 
bacteria from the intestine in a rat model of IRI (Aksoyek et al., 2002). In a rat model of 
intestinal transplantation, Sola et al. identified a protective pathway initiated by IPC that
41involves  the  activation  of  NO  synthesis  (Sola  et  al.,  2001)  .  This  increase  of  NO 
synthesis  was  short-lived  and  detected  at  the  end  of preconditioning.  The  use  of L- 
NAME eliminated this protection.
Davis  et al.  showed that IPC completely prevented the expression of P-selectin  in 
the  ischemic  intestine  and  abolished  the  IRI  induced  leukocyte  rolling  (Davis  et  al., 
1999). These powerful anti-inflammatory actions of BPC were thought to be triggered by 
stimulation of adenosine Al receptors during the period of preconditioning.
The  protective  effect  of  IPC  has  also  been  associated  with  a  decrease  of  xanthine 
accumulation and a diminished conversion of XDH to XO (Sola et al., 2000). There is 
evidence that IPC reduces apoptosis in the intestinal epithelial cells and this is attributed 
to significant expression of Bcl-2 (Cinel et al., 2003).
Tamion et al. in a rat model of haemorrhagic shock followed by resuscitation showed 
that  IPC  reduced  fluid  requirements,  lung  oedema,  lactate,  TNF-a  production  and  a 
more than fivefold increase of intestinal haem oxygenase-1   (HO-1) expression (Tamion 
et al., 2 0 0 2).
1.5.2  Antioxidants
The human body is endowed with many natural antioxidants which unfortunately are 
not capable of protection against the attack of oxidant formation during IR injury. It has 
been shown in many animal studies that supplementation of these anti-oxidants is 
helpful in reducing IR induced tissue damage (Table 1.2). The agents that have been 
used are allopurinol (Ahmadinejad et al.,  1996),  superoxide dismutase (SOD)
42(Cuzzocrea et al, 2001), iron chelator (e.g.desferrioxamine) (Balogh et al, 2002) ,N- 
acetyl cysteine (NAC) (Cuzzocrea et al., 2000), ethanol (Yamaguchi et al., 2002), 
ascorbic acid (Nakamura et al.,  1997), tocopherol (Gunel et al.,  1998), pentoxyfylline 
(Sener et al., 2001;Hammerman et al.,  1999), captopril (Buyukgebiz et al.,  1994)and 
verapamil (Mocan et al.,  1995).
Intravenous SOD mimetic (M40401), when administered  15 minutes prior to 
reperfusion in a model of IRI preserved the architecture of the ileum, reduced the 
expression of cytokines and abolished the expression of P-selectin and ICAM-1 
(Cuzzocrea et al., 2001). In some cases two anti-oxidants are administered 
simultaneously (e.g. SOD and catalase) in an attempt to block the oxidants at more than 
one stage of formation (Simpson et al.,  1993). Kojima et al. showed that an intra- 
duodenal infusion of antioxidants glutathione, rebamipide and dymethylsulfoxide 
attenuated the increase in apoptosis in the intestinal mucosa after IR injury (Kojima et 
al., 2003). A newly developed free radical scavenger, edaravone has shown to be 
effective in reducing IR injury of the intestine through its anti-cytokine and anti- 
chemokine effects (Tomatsuri et al, 2004).
43Table 1.2. A list of antioxidants used against reperfusion injury in the intestine
Agent Author Species Mechanism Outcome
Allopurinol Ferrer(Ferrer et 
al,  1998)
Rats oxidative stress, 
scavenging free 
radicals
itissue damage, i   Amylase, 
iMDA, iGSH & 4-MPO
Anti-thrombin III Ozden(Ozden et 
al.,  1999)
Rats lipid
peroxidation
1 MDA,1 MPO,Itissue dam
Bilirubin Hammerman(H 
ammerman et 
al., 2 0 0 2)
Rats lipid
peroxidation
|blood and intestinal 
thiobarbituric
acid & tissue damage
Ceran(Ceran et 
al, 2 0 0 1)
Rats anti-oxidant itissue damage
Edaravone Tomatsuri(Tom 
atsuri et al., 
2004)
Rats anti- cytokine & 
chemokine
itissue damage,iMPO,|TB^ 
reactive substances, |CINC- 
protein & J,CINC-1 mRNA
Captopril Buyukgebiz(Bu 
yukgebiz et al., 
1994)
Rats free radical 
scavenger
i  M DA,i MPO,itissue dam
Cyclosporin Puglisi (Puglisi 
etal.,  1996)
Rats free radical 
scavenger
itissue damage
Desferrioxamine Balogh (Balogh 
et al., 2 0 0 2)
Rats lipid
peroxidation
|MDA
Epidermal Berlanga Rats lipid jMDA, i  MPO, itissue
44growth factor 
(EGF)
(Berlanga et al., 
2 0 0 2)
Rabbits peroxidation damage
Glutamine Harward Rats lipid TGSH,iconjugated diene
(Harward et al., peroxidation (a by-product of lipid
1994) peroxidation)
Melatonin Ustundag(Ustun Rats oxidative stress |SOD, |  glutathione peroxide
dag et al., 2 0 0 0)
Kazez (Kazez et Rats lipid jMDA &itissue damage
al., 2 0 0 0) peroxidation
N-acetyl cysteine Sun(Sun et al., Rats neutrophil i  MPO & ^endothelial
2 0 0 2) infiltration permeability
Nitroglycerine Dun(Dun et al., Rats Lipid itissue damage, |MDA
2 0 0 1) peroxidation &|LDH
Pyruvate Cicalese(Cicale Rats free radical itissue damage,! free radica
s  eetal.,  1996) scavenger neutrophil infiltration
Rapamycin Puglisi(Puglisi Rats free radical itissue damage
et al.,  1996) scavenger
SOD Riaz(Riaz et al., Rats oxidative stress !neutrophil rolling & adhesk
2 0 0 2b)
Trimetazidine Tetik(Tetik et Rats free radical |MDA, i  MPOitissue dama
al.,  1999) scavenger
Verapamil Mocan(Mocan Rats oxidative stress itissue damage
et al.,  1995)
45CINC, cytokine-induced neutrophil chemoattractant; GSH, glutathione; HO-1, heme 
oxygenase-1; iNOS ,inducible nitric oxide synthase; LDH, lactate dehydrogenase; MDA 
, malonyldialdehyde; MPO, myloperoxidase; NO, Nitric Oxide; RNA, ribonucleic acid; 
SOD, superoxide dismutase; TBA*, thiobarbituric acid.
*TB A-an indicator of lipid peroxidation
461.5.3 NO Supplementation
Supplementation of NO has been shown to attenuate IR injury in intestine in cats and 
dogs (Kawata et al, 2001;Aoki et al,  1990).Kalia et al. showed that a spontaneous NO 
donor (FK-409) reduced both intestinal and lung damage after IRI of the intestine in rats 
(Kalia et al., 2002). It was also shown that inhaled NO at low concentration exerts 
profound anti-leukocyte adherence effects in cat and dog IRI (Fox-Robichaud et al, 
1998). Whereas the use of selective inhibitors of iNOS have shown to be beneficial, the 
use of non-selective inhibitors have been shown to be deleterious in intestinal IR injury 
(Luo et al, 2001).Recently, Naito et al demonstrated that the administration of a 
selective iNOS inhibitor, ONO-1714 attenuated IRI of the intestine (Naito et al, 2004). 
Intraluminal administration of nitroglycerine, a potent exogenous NO donor prevented 
the increase in intestinal permeability associated with IR injury of the intestine (Khanna 
et al, 2003).
1.5.4 Anti-complement Therapy
IR injury is significantly reduced by complement inhibition, complement depletion or in 
complement deficient animals (Collard and Gelman, 2001) .Administration of a 
Complement (C5a) receptor antagonist has been shown to protect the intestine against 
the IR injury in a murine model (Heller et al,  1999). Arumugam et al showed that 
administration of an orally active C5a receptor antagonist was highly effective in 
reducing the damage to the intestine in a rat model (Arumugam et al, 2002b). The anti- 
C5 antibody inhibited TNF-alpha expression and tissue injury. Zhao et al showed that 
the use of a anti-murine C5 monoclonal antibody decreased neutrophilic infiltration of 
both the intestine and the lungs (Zhao et al, 2002). Williams et al showed that the 
administration of a complement inhibitor of soluble complement receptor 1  (sCR 1) 
attenuated intestinal mucosal injury, reduced the intestinal vascular hyperpermeabilty
47and increased the survival in a rat model (Williams et al.,  1999). It has been 
demonstrated recently that the administration of human Cl esterase inhibitor has been 
shown to attenuate reperfusion injury in a mouse model of intestinal IR injury (Karpel- 
Massler et al., 2003).
1.5.5  Anti-leukocyte therapy
There are broadly three therapeutic strategies to attenuate leukocyte mediated IR injury. 
These are namely: (a) inhibition of leukocyte activation, (b) inhibition of leukocyte 
adhesion molecule synthesis and (c) inhibition of leukocyte-endothelial adhesion 
(Collard and Gelman, 2001).
The activation of leukocytes in IR injury is aided by the release of inflammatory 
mediators such as leukotriene-B4, platelet activating factor (PAF), tumour necrosis 
factor-a (TNF- a) (Panes et al.,  1999). Studies have shown that the use of LT-B4 
antagonists (Souza et al., 2000b), PAF antagonists (Souza et al., 2000a;Sun et al., 2002) 
and the use of TNF-a inhibitors (Souza et al., 2001) limits IR induced leukocyte 
activation.
A second strategy to attenuate leukocyte mediated IR injury has been to inhibit 
leukocyte adhesion molecule synthesis. Transcription factors regulating leukocyte 
adhesion molecule synthesis, such as NF-kB are the targets for BAY 11-7085 (Ikappa B 
inhibitor) (Zou et al., 2003)and a  melanocyte stimulating hormone (Hassoun et al., 
2002).
The third strategy is to limit the leukocyte-endothelial adhesion. Riaz et al. showed that 
the use of allopurinol and SOD reduced leukocyte rolling and adhesion in a dose 
dependent manner (Riaz et al., 2002b). The use of monoclonal antibodies directed
48against adhesion molecules reduces severity of IR injury in the intestine. One restraining 
factor that is limiting the clinical use of monoclonal antibodies against leukocyte- 
endothelial interaction is the possibility of an immune reaction (Harris and Granger, 
1997). Pre-treatment with an anti P-selectin antibody have been shown to reduce 
leukocyte adhesion by about 85% and that IRI induced leukocyte adhesion was 
significantly reduced in leukocyte function antigen -1 (LFA) deficient mice (Riaz et al., 
2002a). However, Carmody et al demonstrated that eliminating P-selectin by using P- 
selectin knockout mice attenuated reperfusion injury and this beneficial effect was 
found to be independent of neutrophil adhesion (Carmody et al., 2004). The 
administration of anti-LFA-1 antibodies have been shown to be effective in improving 
allograft survival in small bowel transplantation (Bowles et al., 2000). A non exhaustive 
list of anti-leukocyte and anti-inflammatory agents used in IRI of the intestine is shown 
in Table 1.3.
Table 1.3 A list of anti-leukocyte and anti-inflammatory agents used against reperfusion 
injury in the intestine
49Agent Author Species  Mechanism
a-Melanocyte
Anti-IL-8 antibody
Anti-TNF
antibody
BAY-11-7095
BN 52021
CP-105,696
CINC Ab
Hassoun(Hassou  Rats
n et al., 2002)
Tsuruma(Tsururn  Rats
a et al., 1996a)
Koksoy(Koksoy  Rats
et al., 2001)
Zou(Zou et al.,  Rats
2003)
Droy-  Rats
Lefaix(Droy-
Lefaix et al.,
1991)
Souza(Souza et  Rats
al., 2002)
Yagihashi(Yagih  Rats
Inhibition of NF-K B
Inhibition of IL-8 
expression
Inhibition of TNF 
expression
Inhibition of I-kappa B 
PAF antagonist
Inhibition of 
leukotrienes
Inhibition of TNF
Outcome
^tissue damage & J,MPO
jtissue damage & TNF-a
^neutrophil sequestration
jtissue damage > 30 mins of reperfusion 
& ftissue damage 6hrs > 
reperfusion,J,MPO,|IL-6 & jICAM-1
^tissue damage
jtissue damage, J,vascular permeability & 
|TNF-a in the lungs & intestine
jtissue damage & J,TNF-a
50Cyclic peptide 
AcF (OpdChaWR)
Ethanol
Foetal bovine 
serum
FK-409
FR-167653
ashi et al., 1998)
Arumugam(Aru  Rats 
mugam et al.,
2002b)
Yamaguchi(Yam  Mice 
aguchi et al.,
2002)
Chen(Chen etal.,  Rats 
2002)
Kalia(Kalia et al.,  Rats
2002)
Kawata(Kawata  Dogs 
et al., 2001)
Yamamoto(Yama  Rats 
moto et al., 2001)
Takeyoshi(Takey  Dogs 
oshi etal., 1996)
expression
Complement antagonist
Inhibition of neutrophil 
infiltration
Inhibition of IL-8
NO donor
NO donor
Inhibition of TNF-a & 
IL-1
Inhibition of TNF-a & 
IL-1
^tissue damage, |TNF-a & inhibition of 
IR induced neutropenia
I leukocyte rolling & adhesion 
jIL-8
Maintains WCC, jvilli-leukocyte 
adhesion,J, lung damage & f survival
jtissue damage
jtissue damage, !TNF,|IL-1 & j,AST 
jtissue damage
51GPI6150
Glycine
Heparin binding 
EGF
Hepatocyte growth 
factor
Hyperbaric
oxygen
IL-10
Inosine
Mazzon(Mazzon  Rats
et al., 2002)
Lee(Lee et al.,  Rats
2002)
Iijima(Iijima et  Mice
al., 1997)
Xia(Xia etal.,  Rats
2003)
Kuenzler(Kuenzl  Rats
er et al., 2002a)
Yang( Yang et al.,  Rats
2001)
Lane(Lane et al.,  Mice
1997)
Dowdall(Dowdal  Rats
1 et al., 2002)
p-selectin & ICAM-1 
blocker
Inhibition of neutrophil 
infiltration
Inhibition of IL-6
Inhibition of neutrophil 
infiltration
Inhibition of TNF 
Inhibition of TNF 
Cytokine attenuation 
Cytokine attenuation
Improves mean BP, ^tissue damage, 
jMPO & | survival
t mucosal protein & DNA,J,MPO
jtissue damage, jbacterial 
translocation&j survival
^expression of P/ E- selectins,VCAM-l & 
ICAM-1
jcaspases
iTNF-a & lung MPO
jtissue damage, j TNF-a ,|lung MPO & 
4IL-6
jtissue damage,! gut permeability & 
jlung MPO
52L-Propionyl
Carnitine
Lipocortin-1
L-Arginine
Lexipafant
M40401
Magnolol
Methyl
Prednisolone
P-selectin
glycoprotein
ligand
Stroh(Stroh etal.,  Rats
1998)
Cuzzocrea(Cuzzo  Rats 
crea etal., 1997)
Wamecke(Wame  Rats 
eke et al., 2002)
Sun(Sun etal.,  Rats
2002)
Cuzzocrea(Cuzzo  Rats 
crea et al., 2001)
Loong(Loong et  Rats 
al., 2001)
Wamecke(Wame  Rats 
eke et al., 2002)
Farmer(Farmer et  Rats 
al., 2002)
Inhibition of neutrophil 
infiltration
Inhibition of neutrophil 
infiltration
Inhibition of TNF-a & 
IL-6
Platelet activating 
factor antagonist
p-selectin blocker & 
inhibition of ICAM-1
Inhibition of EL-6
Inhibition of TNF & 
IL-6
p-selectin blocker
fsurvival, maintains mean arterial 
pressure, ^tissue MPO
Maintains blood pressure, ^tissue MPO & 
jtissue damage
jtissue damage,J,TNF-a,^hyaluronic acid 
& |IL -6
J,endothelial permeability & J,MPO
Improved blood pressure, jMDA & 
jMPO
jtissue damage &|IL-6
j tissue damage,J,'TNF-a,^hyaluronic acid 
& J, IL-6
j tissue damage, |IL-1 l,IL-6 ,interferons 
& jMPOPentoxifylline
Pirfenidone
Rolipram
UK 74505
Sener(Sener et  Rats
al., 2001)
Arumugam(Aru  Rats
mugam et al.,
2002a)
Souza(Souza et  Rats
al., 2001)
Souza(Souza et  Rats
al., 2000a)
Inhibition of neutrophil 
infiltration
Inhibition of TNF-a
Inhibition of TNF-a
Platelet activating 
factor antagonist
jMDA^MPO & fglutathione
^tissue damage, & |TNF-a
^intestinal & lung permeability, 
^recruitment of neutrophils,|IL-10, jTNF- 
a in both lungs & intestine
jTNF-a, jMPO, jtissue damage & 
mucosal permeability
54Ab,  antibody;  AST,  aspartate  aminotransferase;  BP,  blood  pressure;  CINC,  cytokine-induced 
neutrophil  chemoattractant;  DNA,  deoxyribonucleic  acid;  EGF,  epidermal  growth  factor;  GSH, 
glutathione;HO-l, haem oxygenase-1;ICAM , intercellular adhesion molecule; IL, interleukin; iNOS 
,inducible  nitric  oxide  synthase  ;  LDH,  lactate  dehydrogenase;  MDA  ,  malonyldialdehyde;  MPO, 
myloperoxidase;  NF-K B,  nuclear factor kappa -B;  NO,  Nitric  Oxide;  SOD,  superoxide  dismutase; 
TNF, tumour necrosis factor; VCAM, vascular cellular adhesion molecule; WCC, white cell count.
551.5.6 Perfluorocarbons (PFCs)
Perfluorocarbons  are  hydrocarbon  molecules  in  which  hydrogen  atoms  are  replaced  by 
fluorine. They can dissolve 20 -25 times more oxygen than plasma at room temperature. The 
release of oxygen is facilitated by a low oxygen-binding constant causing a linear relationship 
between  oxygen  saturation  and  partial  pressure.  This  results  in  release  of  oxygen  to  the 
tissues. Several studies have been shown that PFCs attenuate IR injury of the intestine (Floyd 
etal., 1987;01dham et al.,  1987;Ricci etal.,  1985).
Intraluminal  administration  of  oxygenated  PFCs  into  the  intestine  has  been  shown  to 
preserve  mucosal  function  and  integrity  after  IR  injuryof  the  intestine  (O'Donnell  et  al., 
1997).  Ohara  et  al.  showed  that  peritoneal  lavage  with  PFCs  reduced  the  intestinal  and 
pulmonary  damage  following  IR  injury  of  the  intestine  (Ohara  et  al.,  2001).Whereas 
Vejchapipat et al.  demonstrated that an extraluminal  administration of PFCs did not protect 
the intestine from IR injury in a rat model (Vejchapipat et al., 2002). The small intestine when 
placed  in  a bag  containing  PFCs  attenuated  the  expression  of cytokines  and  decreased  the 
intestinal damage in a rat model of IR injury (Fujino et al., 2003a). Partial liquid ventilation 
with PFCs  have been  shown  to  reduced remote  organ  injury by reducing  the  lung  damage 
(Shashikant et al., 2002).
1.5.7 Enteral feeding
Enteral nutrition has been shown to reduce the death rate and remote organ injury in a mouse 
model (Fukatsu et al., 2001). Enteral feeding maintains the mucosal immunity and the 
resistance to infections. Fukatsu et al. showed that five days of gut “starvation” with 
parenteral nutrition increases ICAM-1 and P-selectin expression, thereby attracting the PMNs 
to the intestine compared with enterally fed animals (Fukatsu et al., 2000).These ICAM-1 
changes were reversible with reinstitution of enteral feeding. Five days of re-feeding the 
parenterally fed mice with chow returned ICAM-1  levels to normal. Further more, lack of
56enteral feeding has shown to alter the levels of IL-4 and IL-10 in the lamina propria (Wu et 
al,  1999). IL-4 and IL-10 inhibit endothelial expression of ICAM-1.
1.5.8  Glutamine Supplementation
Glutamine considered to be a non-essential amino acid, appears to be a conditionally essential 
nutrient during serious injury (Lacey and Wilmore,  1990).Glutamine is the most abundant 
amino acid in the plasma and skeletal muscle under normal physiological conditions, but 
levels fall substantially after injury or surgery (Askanazi et al,  1980). Several studies 
demonstrate that L-glutamine and glutamine dipeptide (glycyl-glutamine and alanyl- 
glutamine) supplemented parenteral nutrition and L-glutamine-supplemented enteral feeds 
decrease bacterial translocation, diminish experimental colitis and enhance mucosal 
adaptation with refeeding or following bowel resection (Wilmore, 1999;Ziegler et al,  1999). 
In a porcine model of segmental small bowel autotransplantation, Li et al showed glycyl- 
glutamine enriched parenteral nutrition significantly increased graft mucosal glutamine and 
protein levels and decreased intestinal permeability and bacterial translocation (Li et al,
1999). Of interest, in a rat small bowel transplantation model, significantly improved jejunal 
graft maltose absorption and post-transplantation mortality were demonstrated when 
harvested grafts were cold-preserved in 1  % L-glutamine versus saline alone or in University 
of Wisconsin preservation solutions (Sakawaki et al,  1998).
Intravenous infusion of L-glutamine has been demonstrated to increase the cytoprotective 
HO-1 and the antioxidants GSH and SOD, with concomitant decrease of TNF-a in IR injury 
of the intestine (Tamaki et al,  1999). Glutamine-enriched tube feeding was shown by Zhang 
et al to enhance transplanted small bowel growth, nutrient absorption and mucosal barrier 
function (Zhang et al, 1995). Ikeda et al in a mouse model of IR injury of the intestine 
showed that supplementation of TPN with glutamine partially supports mucosal immunity by
57preserving respiratory and intestinal IgA levels, maintaining the proper IgA-stimulating 
cytokine milieu within the intestine, reducing intestinal ICAM-1  expression and neutrophil 
adhesion (Ikeda et al., 2002). Wischmeyer provided evidence that glutamine enhances heat 
shock protein (HSP) expression and thereby confers protection against a variety of stressful 
stimuli (Wischmeyer, 2002;Kelly and Wischmeyer, 2003). Another probable mechanism is 
that glutamine given intravenously increased mucosal glutathione (GSH) levels and attenuates 
IR injury induced cell membrane lipid peroxidation (Harward et al.,  1994).
1.5.9  Glycine Supplementation
L-Glycine, a non-essential amino acid protects the intestine from IRI (Lee et al., 2001;Lee et 
al., 2002;Iijima et al.,  1997). Glycine has an impressive catalogue of functions such as anti­
inflammatory, immunomodulatory and direct cytoprotective functions (Lee et al., 2001;Lee et 
al., 2002;Grotz et al., 2001). Iijima et al. showed that the administration of 20% glycine 
attenuated mucosal damage, preserved the intestinal protein content, reduced bacterial 
translocation and improved the overall survival in a murine model (Iijima et al.,  1997). 
Glycine acts on inflammatory cells such as macrophages to suppress the activation of 
transcription factors and the formation of free radicals and inflammatory cytokines (Kelly et 
al., 2003). Recently, Jacob et al. demonstrated that supplementation of glycine caused a 
downregulation of pro-apoptotic bax and caspase-3, whereas bcl-2 was upregulated (Jacob et 
al., 2003).
1.6  Conclusions
IR injury of the intestine is a complex, multi-factorial pathophysiological process that 
involves the actions of oxygen derived free radicals, cytokines, nitric oxide and PMNs.
Despite the complexity, attenuation of the reperfusion injury through ischemic and 
pharmacological preconditioning has been successfully applied to animal models of intestinal
58IR injury. IPC has been found to be the most promising strategy against IR injury during the 
last few years, appearing to increase the tolerance of the intestine to reperfusion injury. 
However, although IPC has been shown beneficial in the human heart and the liver, 
prospectively controlled studies in humans involving IPC of the intestine is lacking. Research 
focussed on the application of novel drugs that can mimic the effects of IPC to manipulate the 
cellular events during IR injury of the intestine is obligated.
59Chapter 2 Materials and Methods2.1 Animals
2.1.1  Animal preparation and surgical procedure
The study was conducted under a project license granted by the home office in accordance 
with the Animals (Scientific Procedures) Act 1986. Male Sprague- Dawley rats, each 
weighing 250- 300g were used for the experiments. All animals were kept in temperature 
controlled environment with 12 hours light- dark cycle and allowed tap water and standard rat 
chow pellets ad libitum. Animal research protocols were approved by the hospital ethics 
committee.
Animals were anaesthetised using isoflurane (Baxter, Norfolk, UK) and allowed to breathe 
spontaneously via concentric mask connected to an oxygen regulator during the procedure. 
The animal’s body temperature was maintained at 36-38 °C using a heating pad (Harvard 
apparatus Ltd., Kent, UK) and monitored with a rectal temperature probe. The Arterial 
oxygen saturation (SaC>2) and heart rate (HR) were continuously monitored with a pulse 
oximeter (Ohmeda® Biox 3740 pulse oximeter, Ohmeda, Louisville, Colorado, USA). The left 
carotid artery was cannulated with a polyethylene catheter (0.76-mm inner diameter, Portex, 
Kent, UK) and connected to a pressure transducer for monitoring of mean arterial blood 
pressure (MABP). The right jugular vein was cannulated with a smaller polyethylene catheter 
(0.40-mm inner diameter, Portex, Kent, UK) for administering normal saline (1 ml/lOOg body 
weight/hr) to compensate for intra-operative fluid evaporation. All animals had a bolus of 
heparin (20U/kg, intravenously) to prevent potential thrombus formation in the ischaemic 
segment of the intestine due to haemostasis.
61Laparotomy was carried out through a midline incision. The superior mesenteric artery 
(SMA) was identified and dissected out from the mesentery to enable the passage of a 4/0 
vicryl™ (Ethicon, Edinburgh, UK) suture loop. The SMA was occluded according to the 
method described by Arumugam et a/(Arumugam et al, 2002b). The free ends of the vicryl 
suture were then passed through a 5 cm segment of polyethylene tube (1.4- mm inner 
diameter). The tube was then gently advanced over the suture onto the mesentery and fixed in 
place with a haemostat. Reperfusion started when the haemostat was released. The animal’s 
abdomen was covered with a plastic wrap (Saran wrap) to prevent fluid evaporation. At the 
end of the experiment the animals were killed by exsanguination.
2.1.2  Blood and tissue sampling
At the end of the reperfusion period, blood samples (1 ml each) were collected from 
the inferior vena cava for the mesurements of plasma Lactate dehydrogenase, alanine 
transminase, aspartate transminase. Samples were heparinised and centrifuged at 2,000 g for 
10 minutes at room temperature to sediment the erythrocytes.  The plasma supematent was 
removed and stored at -80 °C until required for assay.
Sections  of ileum  were  (1)  freeze  clamped  in  liquid  nitrogen  for  haem  oxygenase 
determination and immediately stored at -80 °C for western blotting of HO-1, and (2) fixed in 
10% formalin for histological  study.  Biopsies of the lung tissue were obtained at the end of 
the reperfusion were fixed in 10% formalin for histological analysis.
2.2.  Assessment of intestinal microvascular perfusion by laser Doppler 
flowmetry
2.2.1  Introduction
62The laser Doppler flowmetry (LDF) which was first used in 1972 by Riva et al. to 
measure the retinal microcirculation in rabbits (Riva et al.,  1972) has been used widely in the 
study of a variety of transparent tissues such as the web of frog (Koyama et al.,  1975), 
mesentery of the mouse (Bom et al.,  1978), hamster cheek pouch (Einav et al.,  1975), human 
skin (Holloway, Jr. and Watkins,  1977) and testicular blood flow(Damber et al.,  1982). This 
technique has been subsequently used in the study of various organs perfusion such as the 
pancreas(Hosotani et al.,  1985), the kidneys (Hansell and Ulfendahl,  1986), intestine 
(Shepherd and Riedel,  1982) and the liver (Koti et al., 2002b).
2.2.2 Principles
The measurement of blood flow with the aid of LDF is based on the detection of a 
shift in the frequency of the backscattered light after the moving red blood cells (RBCs) are 
hit by an incident collimated laser beam according to the Doppler principle. When a beam of 
laser comes into contact with the tissue, the backscattered light is composed of two portions, 
the first consists of the portion from static tissue matrix, which has not been Doppler shifted, 
and the second portion is composed of a broad spectrum of frequencies from interaction with 
the moving RBC’s. Therefore, the Doppler signal varies linearly with the product of the total 
number of moving RBCs in the measured volume of a few cubic millimeters multiplied by the 
mean velocity of these RBCs. The LDF measurements are expressed in arbitrary perfusion 
units (flux). The application and reproducibility of LDF measurement for assessment of 
intestinal microcirculation has been validated in both experimental animals (Ahn et al.,  1985) 
and human small bowel transplantation (Corbett et al., 2000).
2.2.3 The equipment
63A commercial laser Doppler flowmeter (LDF) was used. The basic structure of a LDF 
consists of a probe, optic fibres and the instrument. The probe transmits laser light to tissue 
via optical fibre and back scattered light return from tissue to the flowmeter, then to two 
separate photo-detectors in the instrument.
2.2.4 Calibration of Laser Doppler flowmeter
The intestinal microvascular blood flow in this study was assessed using a commercially 
available dual channel surface LDF (DRT4, Moor Instruments Ltd., Axminster, Devon, UK) 
(Figure 2.1). The LDF was calibrated before each study against a standard reference 
(Brownian motion of polystyrene microspheres in water) provided by the manufacturer.
2.2.5 Recording of the intestinal microvascular blood flow
The LDF technique has been widely validated to estimate perfusion in the gastrointestinal 
tract (Ahn et al.,  1985;Corbett et al., 2000;Feld et al.,  1982;Shepherd and Riedel, 
1982;Thollander et a l,  1997). To minimise any disturbance to blood flow by the LDF probe 
pressure on the tissue, the probe was mounted on a probe holder so that the actual probe was 
just in contact with the intestinal surface without any pressure applied by the weight of probe. 
The probe was placed to a fixed site on the intestine to avoid any error due to anatomical 
variation in the microcirculation.
Data from the continuous measurement by LDF was collected at the relevant points in each 
experiment and calculated as a mean of 1-minute data.
64Moor Instrunrvnts
Figure 2.1. Dual channel surface laser Doppler flowmeter and its probes 
(DRT4, Moor Instruments Ltd., Axminster, UK).2.3. Assessment of intestinal tissue oxygenation by near infrared 
spectroscopy
2.3.1  Principles
Near infrared spectroscopy (NIRS) is a non-invasive optical method that can assess oxygen 
availability and consumption within a biologically living tissue. The evaluation of oxygen 
delivery to tissues is crucial as it assures that adequate oxygen is available for oxidative 
phosphorylation to proceed at a rate matching with the energy needs of the cell. Oxidative 
phosphorylation requires an intact mitochondrial electron transport system wherein NADH 
and FADH2 from the tricarboxylic acid cycle are re-oxidized and oxygen is reduced by four 
electrons to form water, accompanied by generation of adenosine tri-phosphate (ATP) (Fig 
2.2).
In vivo application of NIRS was first described by Jobsis in 1977(Jobsis, 1977). NIRS utilizes 
the ability of NIR light (700-1000 nm) to pass through liver, intestine , brain with much less 
scattering than occurs with shorter wavelengths of light. The interactions of light within the 
tissue involves the combination of reflectance, scattering and absorption which depends upon 
many factors including the light wavelength and the illuminated tissue type (Jobsis,  1977). 
Although in the NIR region of the spectrum the absorption of light by oxyhaemoglobin 
(HbC>2), deoxyhaemoglobin (Hb) and cytochrome oxidase (Cyt Ox) decreases significantly, 
compared to that observed in the visible region of the light, their absorption spectra remain 
different allowing spectroscopic separation of the two compounds using only a few 
wavelengths(Cope et a l, 1988;Wray et al.,  1988).
The technique of NIRS relies upon two main physical properties: (1) the relative transparency 
of biological tissue to light in the NIR region of the spectrum and (2) the existence of different
66tissue chromophores with characteristic absorption spectra in the NIR light spectrum (Elwell 
et al.,  1994;Wray et al.,  1988)(Fukatsu et al.,  1999). In tissue with homogeneous scattering 
the calculation of light attenuation and the relationship between the optical absorption and 
chromophore concentration may be described by a modified Beer - Lambert’s law. The law 
modifications include (a) an additive term, G, due to scattering losses and (b) a multiplier, to 
account for the increased optical pathlength due to scattering. This law can be used to convert 
the obtained optical densities to concentration changes of Hb, HbC>2, and Cyt Ox in pmole/L 
per optical pathlength (Cope et al.,  1988;Wray et al.,  1988;Fukatsu et al.,  1999): A = a. c. d.
B + G.
where A is the attenuation of light (optical density), a  is the absorption coefficient of the 
chromophore (pmole^.cm1), c is the concentration of the absorbing compound (pmole/L) and 
d is the geometrical distance between the points where light enters and leaves the tissue (cm). 
B the differential pathlength factor (DPF) which accounts for the increase in optical 
pathlength due to light scattering (which causes the optical pathlength to be greater than d) 
and G is a constant geometrical factor which accounts for loss of photons by scattering. As G 
cannot be quantified in vivo and is dependent upon the scattering coefficient of the tissue 
interrogated, it is not possible to measure the absolute concentration of the chromophore in 
the tissue from measurement of the absolute attenuation. If a, B, and d are known and G 
assumed to remain constant during measurement, we can measure the change in the 
chromophore concentration (Ac) from measuring the change in attenuation (AA) from the 
following formula: Ac = AA / a. d. B.
Since the absolute concentration of tissue chromophores are unknown and cannot be 
calculated due to the effect of light scattering within the tissue, all NIRS measurements are 
expressed as absolute concentration changes (pmole/L) from an arbitrary zero at the start of 
the measurement.
67The absorption coefficients of HbC>2 and Hb can be obtained in cuvette studies on lysed 
human blood, for the oxygenated spectra these cuvettes are bubbled with different oxygen 
saturation (Wray et a l,  1988)(Fukatsu et al,  1999). The absorption coefficient of Cyt Ox was 
obtained in vivo from the brains of experimental animals whose blood had been replaced by a 
blood substitute (fluorocarbon) with exposure to 100% 0 2 or N2 to obtain the oxidised and 
reduced Cyt Ox spectra (De Blasi et al,  1997)(Fukatsu et al,  1999).
B is dependent upon the amount of scattering in the medium which can be measured by ‘the 
time of flight’ method (Delpy et al,  1988).
For simultaneous computation of the changes in concentration of a number of chromophores 
from changes in attenuation at a number of wavelength, a mathematical operation (algorithm) 
can be used which incorporates the relevant absorption coefficient for each chromophore at 
each wavelength (Fukatsu et al,  1999).(Delpy et al, 1988)As there are three chromophores of 
interest in the tissue (HbC>2, Hb, and Cyt Ox) it is necessary to make measurements at a 
minimum of three wavelengths and if more than three wavelengths are used, standard curve- 
fitting analysis may be used to increase the accuracy of the calculated concentration changes 
(Copeetfl/.,  1988;Wray etal,  1988)(Delpy et al,  1988).
2.3.2  Equipment
In its simplest form, the equipment required for a NIRS system includes the following:
(a)  Light sources that can generate multiple wavelengths of NIR light. In order to
elucidate information on Hb02, Hb and Cyt Ox, four wavelengths are generally required.
(b)  Optical bundles (optodes) to transmit the photons from the source to the monitoring 
site and from the monitored site to a detector.
(c)  Photon detection circuitry (e.g., a photomultiplier and integration amplifier).
68(d)  A computer with appropriate software (algorithms) to process the information 
obtained in the recovered light and compare it with the known amount of light delived.
(e)  An information display system.
The NIR spectrometer used in this study is the NIRO 500 (Hamamatsu Photonics K.K., 
Hamamatsu, Japan) (Figure 2.3 and 2/4). This spectrometer is the commercial version of an 
instrument developed by colleagues in the Department of Medical Physics and 
Bioengineering, University College London(Cope et al.,  1988). In the NIRO 500, the light 
source is monochromatic light generated from semiconductor laser diodes (LD). The light is 
produced at four wavelengths (774, 826, 849, and 906 nm).
The light is produced by laser diodes and carried to the intestine via a bundle of optical fibres 
in sequential pulses. The optical fibres are covered by a light proof protective sheath and its 
distal end terminated in a very small glass prism which reflects the light through 90° to direct 
it into the tissue(Elwell et al., 1994). Photons emerging from the intestine are collected by the 
second bundle of optical fibres and detected by a photomultiplier tube (PMT) light detector. 
The incident and transmitted light intensities are recorded and from these the changes in the 
concentration of tissue chromophores ((imole/L) are calculated using an algorithm 
incorporating the known chromophores absorption coefficients and an experimentally 
measured optical pathlength (see below).
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Figure 2.2.  Schematic diagram depicting oxygen delivery in a cell.
Oxygen  is  delivered  to  the  capillary  bed  by  oxyhaemoglobin(Hb02)  following  which  it 
diffuses into the cell and is bound to myoglobin (Mb02) and utilised by cytochrome oxidase 
(Cyt  Ox),  the  terminal  cytochrome  in  the  electron-transport  chain.  Glycolysis  generates 
pyruvate,  which is transported  into the  mitochondria and oxidized by the tricarboxylic  acid 
(TCA) cycle. Reducing equivalents in the form of FADH2 and NADH are produced to enter 
the electron-transport chain  which  generates  ATP by  oxidative  phosphorylation.  The  redox 
state of Cyt Ox is determined by the flow of electrons through the electron-transport chain and 
by the availability of oxygen; thus reflecting the overall  activity of oxidative metabolism in 
the cell.
70Figure 2.3. Near infrared spectrometer
(NIRO 500, Hamamatsu Photonics KK, Hamamatsu, Japan).
71Figure 2.4. NIRO 500 probes and a rubber optode holder.
722.3.3  Recording of intestinal tissue oxygenation in the rat
NIRS probes were mounted inside a probe holder and placed on the serosal surface of the 
intestine at a fixed site in the ileum in all the animals in each experiment to avoid any 
anatomical variation which could influence in tissue oxygenation and blood volume. As a part 
of the modification of this instrument for use on the intestine, a flexible rubber holder was 
made to hold the NIRS probes at a fixed spacing over the intestine surface. This probe holder 
ensured that the sites of light entry and exit are maintained at a constant and known spacing 
distance which minimises the possibility of artefact due to changes in the distance between 
the probe ends. Also, it allows a satisfactory contact between the intestine surface and the 
probe ends (Figure 2.4).
The NIRO includes the facility to set the attenuation and therefore chromophore 
concentration) changes to zero with the NIRO initial setting. Since all the measurements are 
changes from an arbitrary initial zero, this function in important to ensure that artefacts such 
as system drift, optode movement, and excessive light having a minimal effect on the data.
For collection of NIRS data, a sampling time of 1  second was used. The NIRS data were 
continuously collected in a laptop computer connected to the NIRS. These data are the 
changes in light attenuation (optical densities: OD) at four wavelengths due to absorption by
fa
the tissue chromophores. A software program called ONMAIN  (Hamamatsu Photonics K.K., 
Hamamatsu, Japan) was used to convert these data into changes in concentration changes of 
HbC>2, Hb, and Cyt Ox (pmole/L) using the previously defined algorithm in the NIRO 500. 
This was then transferred to Excel® data sheets (Microsoft Company, Seattle, USA) for 
analysis. The data at the relevant time points were collected as the mean of 1-minute data and 
calculated in regard to the baseline value at the start of the experiment.
732.3.4 Limitations
Three practical factors affect the results obtained using NIRS monitoring. First, 
uninterpretable NIRS signals may occur due to movement or motion artefact. Second trend 
monitoring in the same area over a period of time requires maintaining a constant optode 
placement and geometry. Finally when a deep tissue is the area of interest for monitoring, the 
contribution of overlying superficial tissues needs to be considered. This is affected most by 
the chromphore content of the superficial tissues and by optode geometry, specifically, the 
separation distance of the incident light source and the detector.
Optode separation is an important determinant of the area of interrogation by the incident 
photons. In general, photons follow an elliptical path through tissue from the source to the 
detector(Chance et al.,  1992). The shorter the interoptode distance, the less deep is the 
penetration of light and a smaller area of tissue studied. On the other hand, an extreme 
separation of emitter and detector results in increased photon scatter and more absorption of 
photons by tissue chromophores, resulting in a weak signal that may be difficult to interpret.
2.4 Assessment of portal venous blood flow by ultrasound transonic 
flowmeter
2.4.1  Principles
In 1966, the first ultrasound flowmeter was made by Franklin and co-workers, which worked 
on the ultrasound transit-time method. Unlike the Doppler principle that measures the 
frequency shift, the reflected sound from one moving target makes possible the measurement 
of the time differences over a given distance between the upstream and downstream sound 
waves. Similar to LDF, the first ultrasound flowmeter depended on velocity measurement of a
74point over an area of flow and required an assessment of the inner diameter of the vessel to 
determine the flow volume (Transonic-Systems 1993).
2.4.2  The ultrasound flowmeter
The ultrasound flowmeter used in the subsequent studies is shown in Fig 2.5.
The probe of the mentioned ultrasound flowmeter consists of two adjacent sensor windows 
and a metallic acoustic reflector between which lies on the blood vessel. The upstream 
transducer first sends out sound impulses that passe through the blood vessel and the 
surrounding tissue. The impulse then reaches the downstream transducer where the sound 
impulse is converted into a starting signal which is then amplified and sent to a phase 
detector. The sound velocity is elevated as it travels downstream, resulting in shortening of 
transit time of the arriving impulse. The starting signal and the reference signal from a rhythm 
generator from a phase difference that is recorded and saved.
The next cycle is just an exchange in function between the sound wave sender and signal 
converter. The sound wave travelling from the downstream transducer, which now acts as the 
sound wave sender, to the upstream transducer (i.e. signal converter). Upstream travelling 
causes a delay in transit time. The resulting phase shift is then subtracted from the first one to 
give the flow volume independent of the measurements of the blood vessel. The electronic 
detector is so sensitive that the time difference in measuring a flow rate up to 25 ml/min is as 
small as one picosecond.
Many flowmeters require a certain angle between the incident direction of the probe and the 
blood vessel (i.e. the vector of flow). Such a measurement is sensitive to changes in the probe
75direction and disturbances in laminar flows, for example, secondary flows and wavy flow 
patterns arising from the bending course of the blood vessel. The problem is solved by the 
design of the Transonic flowmeter probe which offers a double capturing of a reflected sound 
wave. The vector sum of the two measurements corresponds to the axial flow components. 
This technique makes the flow measurement independent of the flow profile and the incident 
angle of the probe (Transonic-systems 1993). As flow sensitivity is optimised for a specific 
range of vessel diameters, accurate blood flow measurement for blood vessel of different size 
requires different probes (Transonic-systems 1997).
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Figure 2.5. A ultrasound transonic flowmeter
Ultrasonic probe
772.5  Assessment of intestinal microcirculation by intravital fluorescent 
microscopy
2.5.1. Introduction
The first intravital fluorescent microscope (IVFM) was made by Ellinger and Hirt in 
Germany , which was a modified version of the fluorescence microscope (developed in 
the early 20th century) so that it could be used to examine opaque tissues(Kasten,  1993).
The IVFM can be divided into two separate measuring systems. The first represents the 
microscope alone, with the light source, lenses, filters and fluorescence acting as the 
functional elements (Fig 2.6).
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Figure 2.6. Intravital fluorescence microscope -  instrumental components.
78The second system begins with the image seen from the microscope being converted via 
the CCD camera, passing through the frame grabber and onto the computer monitor 
display (Figure 2.7)
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Figure 2.7.5 Image recording system in the intravital microscope
The IVFM used for this study was a custom built Nikon Epi-illumination system with 
filter block set suitable for Texas Red, FITC and DAPI dyes as detailed in table 2.1. 
(Fig 2.8)
Table 2.1. The details of filter set for the Nikon Epi-illumination system.
Fluorochrome Excitation
(nm)
Emission
(nm)
Colour Type of label
DAPI 360 450 Blue Nuclear Stain
FITC 495 525 Green Protein
Conjugation
Texas Red 596 620 Red Protein
Conjugation
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Figure 6.8.The complete setup of intravital microscopy.
802.5.2 Principles
One of the main characteristics of the intra-vital fluorescence microscope is that it 
works in aid of fluorescence for visualisation. The chromophores are excited by an 
external light source; they absorb the energy and pass into an excited energy state. After 
entering the higher energy state, the molecules undergo internal changes.  The electrons 
in certain molecules instead of returning to the ground state enter a metastable state. 
When the molecules pass down to the ground state they emit the excess energy as 
electromagnetic radiation (Sykes et al.,  1991) -  seen as fluorescence. The energy 
between the metastable and ground states is less than the energy absorbed during 
excitation, so the emission wavelength will be of longer wavelength than the absorbed 
or excitation light (Sykes et al,  1991).
The light from the epi-illumination light source (which is usually a mercury arc or 
xenon lamp in standard IVFM setups) first passes through an excitation or short-pass 
(SP) filter allowing only the excitation waves through. These are then passed onto a 
chromatic beam splitter (dichromatic mirror) where wavelengths below a certain value 
are reflected onto the specimen while any above the wavelength value are passed 
through and dissipated. The light hitting the specimen then activates the fluorescence 
probe which produces emission light of a particular wavelength.
A dichromatic mirror allows passage of excitation wavelengths of certain values and 
emission wavelengths of certain values. According to Stokes’ law the wavelength of 
emission is of lower energy and therefore longer wavelength than that of the excitation. 
The dichromatic mirror is designed to allow the transmission of longer emission 
wavelengths and reflect the shorter excitation wavelengths. The three filters are usually 
contained within a filter box as illustrated in figure 2.9.
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82After passing through the dichromatic beam splitter the excitation wavelength then 
passes through a barrier filter that removes any light of shorter wavelength that may 
have mistakenly passed through the dichromatic beam splitter. This emission 
wavelength then passes into a detector that sends the signals to the eye pieces for 
operator observation or into a video camera for image recording.
2.5.3  Components
2.5.3.1 Light source
The light of the IVFM is a fluorescent mercury arc lamp, which is protected in a lamp- 
house. Since the development of epi-illumination, microscope optics has developed 
with the incorporation of laser light sources increasing the resolution of the image and 
improving the signal-to-noise ratio. A rheostat or ballast alters the current applied to the 
lamp to control the intensity of the light produced. In a gas discharge, such as a 
fluorescent lamp, current causes resistance to decrease. This is because as more 
electrons and ions flow through a particular area, they bump into more atoms, which 
frees up electrons, creating more charged particles.
2.5.3.2 Objectives
IVFMs usually use water immersion objectives as these reduce the refractive index in 
living in vivo imaging .The water immersion objective delivers contrast and resolution 
values nearly equivalent to the theoretical limits, and maintains its performance when 
water layers of 80 and 153 micrometers are added between the target specimen and
83cover slip, a simulation of the situation encountered in imaging deep within aqueous 
material such as living cells or tissue.
There are four types of filters in the intra-vital fluorescence microscope system, neutral 
density (ND) filters, an excitation filter, an emission filter and a multi-band pass filter.
Special neutral density (ND) filters are built in the light path to block 90-95% of the 
incidence light passing into the microscope to prevent damage to the eye as well as 
reduce overexposure of fluorescence in specimens (Nikon, 2004). There are three 
neutral density filters which are placed in front of the optical light path to reduce 
illumination without altering the colour balance.
The excitation filter passes only a selected range of wavelengths of light to cause the 
fluorescently labelled specimen to fluoresce and filters the rest. The bandwidth of a 
filter determines the brightness of the fluorescent image. If the bandwidth is narrow 
then the image appears dark but minimal auto-fluorescence and photo-bleaching occur. 
With a wide bandwidth, although the image appears bright, autofluorescence may also 
be detected with the added disadvantage of photo-bleaching (Nikon, 2004).
The emission or barrier filter allows only light wavelengths that have been emitted from 
the specimen. These are usually longer according to Stoke's law. In older epi- 
illumination microscopes only a dichromatic beam splitter is present allowing use of 
one fluorescent dye at a time. However newer developed models have a multi-band pass 
filter or a polychromatic beam splitter that can allow visualisation of three different 
coloured fluorescent dyes.
842.5.3.3 CCD Camera
The image obtained from the IVFM is then recorded by a charged coupled device 
(CCD) camera. For this study a JVC TK-C1360B colour video camera was used. CCD 
sensors are light integrating devices that accumulate photo charges until image readout. 
The CCD chip in the camera contains an array of pixels that transform light (wavelength 
400nm to lOOOnm) into a charge, which during readout is transformed into a voltage.
Once photo charges are shifted to the storage area, images are erased from the CCD 
light sensing area (Cinelli, 1998). New photo charges can not pile up on top of the 
previous images. In video rate CCD cameras, this process occurs at regular video-rate of 
60 Hz in RS 170 format. However the JVC camera used in this study produces an image 
acquisition rate of 50 Hz.
The photo charges are shifted in block from the sensing area to the storage area, then 
each line is individually read to the serial registers and finally photo charges are 
transferred to the output buffers. Each readout cycle is initiated by a vertical sync pulse 
(vertical blanking sync) which activates the parallel driver and triggers the shift block of 
photo charges accumulated in the sensing area to the CCD storage area.
Exposure time is the main factor that determines the sensitivity of CCD cameras. Long 
exposure times improve camera sensitivity and reduce the noise levels of the images, 
since the accumulation of the photo charge in the CCD sensor is proportional to the 
duration of the exposure period .The analogue video images are digitised at varying 
resolutions typically around 8 bits resolution by a frame grabber board.
2.5.3.4  Frame Grabber
85The Matrix Meteor II/Standard frame grabber used in this study allows image 
acquisition at 25 frames per second. The main parts of the frame grabber are the low- 
pass filter, the decoder, the trigger and the image coding components. The low pass 
filter reduces the high frequency noise and aliasing effects from the analogue CCD 
signals and passes the refined signals to the video decoder. This is the component of the 
frame grabber that performs the actual analogue to digital conversion of the component 
(Y/C) analogue video signals.
2.5.3.5  Image Analysis Software
Adjusting the output image can enhance the resolution and contrast of the image. Light 
intensity and colour are represented in numbers between 0 (black) and 255 (white). 
Converting the image into binary form means it is converted into a black and white 
image. This is done by assigning threshold values which determine the distribution of 
the pixels into two populations either of value 0 or 255.
An image can be transformed into binary form using many different types of software 
packages. Laboratory Universal Computer Image Analysis (LUCIA) is a multi-spectral 
image analysis software developed specifically for image processing independently on 
red, green and blue components and then combining them together into the RGB image 
at the same time. Most Nikon microscopes are supplied with Lucia software and there 
are many versions available denoted by the letter following Lucia. Lucia G is the top of 
the range package that allows 24-bit colour image analysis with the function to allow 
user to create specialized macros.2.6  Haem Oxygenase Assay
2.6.1  Activity assay
HO activity in ileal microsomal fractions was measured using a spectrophotometric 
assay of bilirubin production according to the method described previously (Motterlini 
et al., 1996). Briefly, tissue microsomes were added to the following mixture: MgCH (2 
mM) phosphate-buffered saline (100 mM, pH 7.4; Sigma, UK), rat liver cytosol as a 
source of biliverdin reductase (3 mg total protein), hemin (10 pM), glucose-6-phosphate 
(2 mM), glucose-6-phosphate dehydrogenase (0.2 U) and NADPH (0.8 mM). The 
reaction was conducted in the dark for 30 min at 37°C and terminated by the addition of 
chloroform. All the above chemicals were purchased from Sigma, UK. The amount of 
extracted bilirubin was calculated by the difference in absorption between 464 and 530 
nm and an extinction coefficient of 40 mM‘*cm'1  was used for bilirubin. The total 
protein content of the samples was determined using a colorimetric assay according to 
the manufacturer’s instructions (Bio-Rad, UK) and bovine gamma globulin was used as 
a standard.
2.6.2.  HO expression detcted by Western blotting
Haeme Oxygenase protein was identified using Western blotting. Fresh samples of ileal 
tissue (100- 200 mg) were homogenised in TOXEX buffer (20 mM HEPES  [pH 7.9], 
0.35  mol/L  NaCl,  20%  glycerole,  1%  Nonidet  P-40,  1   mmol/L  MgCU,  0.5  mmol/L 
ethylenediaminetetraacetic acid  [EDTA], 0.1  mmol/L ethylene glycolbis( b-aminoethyl 
ether)-./V,/V-tetraacetic  acid  [EGTA],  100  mmol/L  dithiothreitol  [DTT],  0.1% 
phenylmethylsulfonyl  fluoride  [PMSF],  10 mg/mL aprotinin)  on  ice,  incubated for 30 
minutes, and centrifuged at  13,000 rpm for 5 minutes. For each lane,  100 mg of protein 
was  dissolved  in  10  mL  of  13  sodium  dodecyl  sulfate  loading  dye  and  boiled  for  5
87minutes. A biotinylated protein marker (New England Biolabs, Schwalbach, Germany) 
was  added.  The  samples  were  separated  on  a  12%  sodium  dodecyl  sulfate- 
polyacrylamide gel and transferred to a polyvinylidene fluoride membrane (Immobilon- 
P,  Millipore,  Bedford,  MA)  by  electroblotting  for  2.5  hours  (Semidry  Trans-Blot, 
BioRad, Hercules, CA). The membrane was blocked in a buffer containing 20 mmol/L 
Tris-base (pH 7.6),  137 mmol/L NaCl, 3.8 mL 1  mol/L HC1/L, 0.1% Tween (13 TBST), 
and 5% low-fat dry milk powder for 1  hour and incubated with a rabbit polyclonal anti- 
HO-1  antibody  (1:1,000  dilution;  SPA  895,  StressGen,  Biotechnologies,  Victoria, 
British  Columbia,  Canada)  or  a  mouse  monoclonal  anti-HSP  70  antibody  (1:1,000 
dilution;  SPA 810,  StressGen,  Biotechnologies) in  13  TBST and 5%  low-fat dry milk 
for 2 hours  at room temperature.  After 3  washing steps with  1   X TBST,  a secondary 
anti-rabbit  or  anti-mouse  antibody  (1:10,000  dilution;  ECL-detection  kit,  Amersham 
Pharmacia,  Freiburg,  Germany)  and  horseradish  peroxidase-  conjugated  anti-biotin 
antibody (1:1,000, New England Biolabs)  was added and incubated for  1   hour in  1   X 
TBST  and  5%  low-fat  dry  milk.  Following  2  washing  steps  with  1   X  TBST  and  2 
washing  steps  with  1   X  TBS,  detection  was  performed  by  the  ECL  detection  kit 
(Amersham  Pharmacia)  according  to  the  manufacturer’s  instructions.  After  this  the 
membrane was exposed to a digital camera as part of an electronic imaging system to 
visualise the proteins bound to the antibody.
2.7  Histological investigations
At the end of the experiment, samples of ileum and lungs were removed, fixed in  10 per 
cent neutral buffered formalin and embedded in paraffin; paraffin section 4pm thick 
were cut using a microtome and mounted on slides for haematoxylin and eosin staining.Assessment of ileal injury was performed with light microscopy without knowledge of 
study groups by a scoring system devised by Chiu et al  (table 2.2)(Chiu et al.,  1970).
Table 2.2. Scoring system for assessment of ileal injury.
Grade  Description
0  Normal villi
1   Subepithelial space top of villus
2  Extension of subepithelial space at top of villus with moderate separation of 
mucosa from lamina propria
3  Extensive subepithelial separation from the lamina propria down the sides of 
the villi, ulceration at the villous tips
4  Denuded villi
5  Disintegration of lamina propria
89Chapter 3 Ischaemic preconditioning improves the microvascular perfusion and 
oxygenation following reperfusion injury of the intestine
903.1  Introduction
The effect of ischaemic preconditioning (IPC) on the intestinal microvascular perfusion 
and oxygenation is poorly understood.
The intestine is one of the tissues that is extremely sensitive to ischaemia and it 
demands high blood flow to sustain oxygen consumption, accounting for approximately 
20% of the body’s total oxygen consumption (Bohlen,  1998). Tissue oxygenation 
reflects the adequacy of microvascular perfusion and is the ultimate determinant of 
viability. IR injury is associated with the breakdown of microvascular perfusion with 
subsequent impairment of tissue oxygenation (Turnage et al., 1995). Therefore, changes 
in intestinal tissue oxygenation with IPC may give an important indication of the effect 
of IPC on IR injury.
Near infrared reflectance spectroscopy (NIRS) is one of the methods under 
development for assessing the adequacy of mesenteric tissue oxygenation. Varela et al 
demonstrated that NIRS was able to detect early changes in gastric tissue oxygenation, 
which highly correlated with parameters of mesenteric perfusion (Varela et al., 2001). 
NIRS measures changes in haemoglobin oxygenation which gives useful information 
about extracellular tissue oxygenation(Koti et al., 2002a). NIRS also measures the 
reduction oxidation (redox) changes of the copper center (CuA) of cytochrome oxidase 
(Cyt Ox)(El Desoky et al., 2001) and therefore changes in the redox state of CuA in 
cytochrome oxidase can reflect changes in intracellular oxygenation and mitochondrial 
functional Desoky et al.,  1999).
This study was designed to explore the effect of IPC, on the early phase of small 
bowel IR injury by focussing on the intestinal microvascular perfusion and oxygenation.
913.2  Materials and methods
Animal care and experimental protocols were performed as discussed previously in 
chapter 2.1.1.
3.3.1 Operative procedures
Animals were anaesthetised and operated upon as described previously in chapter 2.1.1.
3.3.2 Experimental protocol
Rats (n=18) were randomly allocated to one of 3 study groups (n=6/group).
Group I. Sham laparotomy, in which the SMA was identified and passage of vicryl 
suture was performed, but without vascular occlusion.
Group II.  IR, in which SMA was occluded for 30 min, followed by a 2 hour period of 
reperfusion.
Group III. IPC+IR, the SMA was occluded for 10 min and released for 10 min. This 
was followed by IR (as in Group II).
3.3.3 Measurement of intestinal microvascular perfusion
Intestinal microvascular perfusion (IMP) was measured by a surface LDF (DRT4, Moor 
Instruments Limited, Axminster, UK) in flux units as described previously in chapter 
2.2.5.  LDF probe was placed on a fixed site on the serosa of the ileum and was held in 
place by a probe holder.  Serosal blood flow has previously been shown to correlate well 
with mucosal flow (Corbett et al., 2000). LDF data were collected continuously at 
sampling rate of 2Hz on computer.
3.3.4 Measurement of intestinal tissue oxygenation
92Intestinal tissue oxygenation was measured using NIRS as described in detail previously 
in chapter 2.3.3. A NIRS adapted algorithm was used to measure continuously intestinal 
Hb02, Hb, and Cyt Ox concentration changes in pmole/L. NIRS was optically
initialised to zero at the start of the experiment. NIRS measurements after ischaemia or 
sham laparotomy were expressed relative to the baseline.
3.3.5 Measurement of portal venous blood flow
It has been reported that IR injury of the intestine is known to profoundly disturb the 
hepatic blood flow (Nakamura et a l, 2001), we studied the effect of IR injury and IPC 
on the portal venous blood flow (PVF). It was monitored continuously in ml/min, using 
a dual Transonic Medical Flowmeter system (HT207, Transonic Medical System Inc, 
New York, US A). (Fig 9). The transonic flowmeter perivascular probe (2 mm diameter) 
was placed around the portal vein (Yang et a l, 2003). This has been considered as a 
suitable technique for estimation of hepatic blood flow (Yang et a l, 2003).
3.3.6 Biochemical assays
Blood samples were taken from the carotid artery at the end of reperfusion. They were 
centrifuged at 2000 g for 10 min at room temperature to sediment the erythrocytes. The 
serum lactate dehydrogenase (LDH), aspartate aminotransferase (AST) and alanine 
aminotransferase (ALT) were analysed on a Hitachi 747 auto-analyzer (Hitachi Ltd, 
Tokyo, Japan) by using commercially available enzymatic kits (Boehringer Mannheim 
Ltd., East Sussex, UK).
3.3.7 Histological investigation
At the end of the experiment, tissue samples of ileum were removed, fixed in  10% 
neutral buffered formalin and embedded in paraffin. Paraffin sections (4pm thick) were
93cut using a microtome and mounted on slides for haematoxylin and eosin (H&E) 
staining.  The histological slides were assessed under light microscopy without 
knowledge of study groups and ileal injury was scored by the method  (table 1) 
described previously by Chiu et al (Chiu et al., 1970).
3.3.8  Data collection and statistical analysis
Data from the pulse oximeter, pressure monitor, LDF, NIRS and the transonic ultrasonic 
system were collected continuously on laptop computer at rate of 2Hz. The data were 
calculated as 1-min averages at baseline, at the end of ischaemia and at 30, 60, 90 and 
120 min of reperfusion. All values are expressed as mean ±standard error of the mean 
(SEM). Analysis of variance (ANOVA) and Bonferroni adjustment for multiple 
comparisons were used unless otherwise stated, where unpaired Student’s Mest was 
used for statistical analysis between groups. p< 0.05 was considered statistically 
significant.
3.4  Results
3.4.1  Systemic haemodynamics parameters
There were no significant changes in HR and SaC>2 throughout the experiment in all 
three groups of animals (p=0.522). In the sham group the MABP did not change 
statistically throughout the experiment (p =0.153). During ischaemia there was a 
significant increase in MABP from the baseline in both IR (87±4 mmHg to  112± 5 
mmHg, p=0.005) and IPC groups (88 ±7 mmHg to 112±5 mmHg, p=0.005). However, 
the MABP did not change statistically as compared with baseline at the end of the 
reperfusion period between all three groups (p =0.765) (Fig 3.1).
943.4.2 Intestinal microvascular perfusion
IMP did not alter significantly during the course of the experiment in the sham group (p 
=0.509). There were significant differences between IR and IPC groups in IMP at the 
initial 30 min of reperfusion and this persisted till the end of the 2 hr reperfusion period 
(42.5±2.8 % in IR vs. 70.8±4.1% in IPC, p<0.001) (Fig 3.2). There was no significant 
difference in IMP at the end of reperfusion in IPC compared to the sham laparotomy 
group (p=0.530).
3.4.3 Intestinal tissue oxygenation
Intestinal tissue oxygenation did not alter significantly during the course of the 
experiment in the sham laparotomy group (Fig 3.3). In IR group, there was a significant 
decrease in HbC>2 and Cyt Ox with concomitant increase in Hb. During reperfusion, 
there was a significant decline in Hb02 and Cyt Ox levels compared to the baseline.
IPC was associated with significant increased levels of Hb02 and Cyt Ox (p<0.001 
IPC vs. IR). The levels of Hb02 increased significantly on reperfusion and this increase 
persisted throughout the reperfusion period. The levels of Hb on reperfusion showed an 
increase from ischaemic levels, however, it was statistically lower compared to the IR 
group.
3.4.4 Portal venous blood flow
PVF was reduced significantly during the period of ischaemia in both IR (17±3 % of 
baseline) and IPC (11±5% of baseline). At the end of the 2 hr reperfusion period IPC 
improved the PVF significantly (42±9% vs. 79±9%; IR vs. IPC, p=0.005). (Fig 3.4).
3.4.5 Biochemical analysis
95At the end of reperfusion, the LDH value in sham group was 364± 88.9|i/L. It increased 
significantly in IR group (1973.8± 306.5[i/L) as compared with sham (P<0.001). 
However, LDH vallue was significantly lower (p< 0.001) in IPC (667.1±86.8ja/L) as 
compared to IR (Fig 3.5).
3.4.6  Histological analysis
IR resulted in a significant increase in the histological score as compared with sham 
group (3± 0.21.0± 0.2; IR vs. IR). IPC reduced the histological score significantly to 
1.5± 0.2 (p =0.009) (Fig 3.6)
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Figure 3.1. Mean arterial blood pressure measurements in all the three groups. Results 
are presented as mean± SEM of 6 animals from each group.
*p=0.005 vs. sham. B, baseline; II,  lOmin of ischaemia; Rl,  10 min of reperfusion.
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Figure 3.2. Intestinal microvascular perfusion (IMP) measured by LDF. For 
comparison, LDF readings were recorded as 100% at baseline. Values are mean ± SEM 
of 6 animals in each group.
* p=0.046 versus  IR;  **  p<0.001  vs.  IR.  B, baseline;  II,  lOmin of ischaemia;  Rl,  10 
min of reperfusion
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Figure  3.4.7  Portal  venous  blood  flow  measured  by  Transonic  Doppler  flow  probe.  For 
comparison, PVF readings were recorded as  100% at baseline. Values are mean ± SEM of 6 
animals in each group.
*p=0.005 vs. IR.  B, baseline; Il,10min of ischaemia; Rl, 10 min of reperfusion.
100L
D
H
 
(
u
/
L
)
2500-1 
2000-  
1500- 
1000-  
500- 
0
Sham  IR
Figure 3.5. Serum LDH levels in all the three experimental groupsFigure 3.6.8 Representative photomicrographs of the ileum (A) in sham operated 
animals showing well preserved villi, (B) subjected to 30 min of ischaemia and 2 hr 
reperfusion (IR)  showing disruption of villous pattern and (C) subjected to IPC + IR- 
depicting well preserved villi.
(H&E, original magnification x 100).
1023.5 Discussion
The present study has clearly demonstrated that IPC improves the intestinal 
microvascular perfusion and oxygenation, while ameliorating IR injury. Serum LDH, 
which was used as a marker for intestinal injury (Sola et al., 2001;Thompson et al., 
1990), reflected intestinal damage in IR group, whereas IPC decreased these levels. 
These results correlated with the histological analysis.
A period of 2 hrs of reperfusion following ischaemia was chosen to assess changes in 
the early phase of reperfusion injury. Experimental data suggest that IR induced 
intestinal injury occurs in a biphasic manner; an early phase of injury that develops over 
the course of 2 hrs of reperfusion and a later progressive phase that develops at 6 to 24 
hrs after reperfusion (Slavikova et al.,  1998). Preconditioning times of 10 min 
ischaemia with 10 min reperfusion have been shown to protect against intestinal injury 
in experimental models of intestinal IR injury (Sileri et al., 2004;Aksoyek et al., 
2002;Vlasov et al., 2002).
LDF was used to measure the IMP. Following reperfusion, changes in IMP demonstrate 
that IR was characterised by no reflow phenomenon, which was abrogated by IPC. The 
increase of IMP within the initial 30 minutes of reperfusion with IPC suggests that the 
mechanism of preconditioning modulating flow in the microcirculation is an immediate 
phenomenon. Therefore, the effect of preconditioning is likely to involve modulation of 
immediate microcirculatory events at the level of capillaries and postcapillary venules, 
because these are the primary sites of IR-induced microcirculatory failure.
103NIRS was used to measure the changes in intestinal tissue oxygenation at the level of 
capillaries. IR was associated with a decrease of HbC>2 and an increase of Hb, reflecting 
the dissociation of oxygen from haemoglobin, as oxygen is extracted by the intestinal 
tissue. These changes reflect reduced blood and oxygen supply to the tissue. The 
reduction in Cyt Ox reflects severe intracellular hypoxia and mitochondrial dysfunction. 
The failure of recovery of Hb02 and a decline in Cyt Ox indicate persistent extracellular 
and intracellular hypoxia due to an inability to fulfil the oxygen demand with the 
reperfusion injury. In contrast, IPC was associated with an increase of both Hb02 and 
Cyt Ox levels. This increase of Cyt Ox suggests that it is mitochondrial preservation 
that contributes to the mechanism of IPC.
Our results demonstrate that induction of ischaemia results in a steep rise of MABP.
This may be mediated by a decrease in the baroreceptor input to the medullary 
vasomotor centre in response to reduced splanchnic perfusion (Hayward and Lefer, 
1998). Reperfusion resulted in restoration of MABP to pre-ischaemic levels.
The portal venous flow did not show any sign of recovery despite reperfusion in the IR 
group. Tumage et al. demonstrated that the SMA blood flow does not return to normal 
on reperfusion but remains low in IR group (Tumage et al., 1996). Thus reduced flow 
through the superior mesenteric vein would necessarily reduce portal venous flow. At 
the end of 2 hrs of reperfusion, IPC improved the portal venous flow significantly.
In summary, the data presented in this chapter showed that IR injury of the intestine 
results in profound derangement of intestinal microvascular perfusion, oxygenation and 
portal venous flow. IPC reversed these effects and attenuated the IR injury of the 
intestine.
104Chapter 4 Protective effects of ischaemic preconditioning on the intestinal mucosal 
microcirculation and lungs following ischaemia reperfusion of the intestine
1054.1.  Introduction
In the previous chapter, we have shown that ischaemic preconditioning (IPC) improves 
the intestinal microvascular perfusion and tissue oxygenation. In this chapter, we 
investigate the effects of IPC on the red blood cell dynamics and leukocyte-endothelial 
interactions using intravital microscopy and examine the role of haem oxygenase. We 
also examine the effects of IR injury of the intestine and IPC on the lung histology. 
Intestinal tissue injury after a period of ischaemia is preferentially localised to the 
mucosal villi, with the underlying submucosal layers being virtually unharmed (Kong et 
al.,  1998). Microcirculatory failure showing impairment of capillary perfusion, 
activation and adhesion of leukocytes and eventual disruption of the mucosal barrier are 
the crucial hallmarks of IR injury in the mucosal villi (Kaminski and Proctor,  1989).
4.2.  Materials and Methods
Animals were anaesthetised and operated upon as described previously in chapter 2.1.1.
4.3.1  Operative Procedures
Animals were anesthetized and operated upon Animals were anaesthetised and operated 
upon as described previously in chapter 2.1.1.
Laparotomy was carried out through a midline incision. The superior mesenteric artery 
(SMA) was identified and occluded with a non-traumatic vessel clamp to induce 
ischaemia. Reperfusion started when the clamp was released. In all animals, the
106mucosal surface was exposed in a segment of exteriorized ileum by making a 30 mm 
incision along the anti-mesenteric border using an electric microcautery.
Following the period of reperfusion, there was macroscopic evidence of patchy necrosis 
along the length of the small bowel. Microscopically, the areas of necroses were 
associated with total stasis of blood flow. This patchy response is consistent with 
previous studies (Kalia et a l, 2002;Kong et a l, 1998). Because of this patchy response, 
the anti-mesenteric incision for the exposure of the mucosa was made in a relatively 
viable segment of the ileum which was associated with area of reflow in order to study 
the effects of IR injury and IPC. The animal’s abdomen was covered with a plastic wrap 
(Saran wrap®, Dow Chemical, Michigan, USA) to prevent fluid evaporation. At the end 
of the experiment the animals were killed by exsanguination.
4.3.2 Experimental Protocol
Rats were randomly allocated to 3 study groups (n= 12/group).
Group 1.  Sham laparotomy, the SMA was identified with no vascular occlusion.
Group 2.  IR, the SMA was occluded for 30 min, followed by a 2 hour period of 
reperfusion.
Group 3. IPC+IR, the SMA was occluded for 10 min and released for 10 min. This was 
followed by IR (as in Group 2).
In each group RBC dynamics were studied on 6 animals and the other 6 animals had 
evaluation of the interactions of leukocyte to the endothelium.
4.3.3 In vivo Fluorescence Microscopy
107The animals were placed on the stage of a Nikon custom built microscope (Nikon, 
Japan) with an integrated heating system where the temperature was maintained at 
37°C. The whole set up was placed on a pneumatic vibration isolation workstation 
(Newport, U.S.A) to minimise vibration. The small bowel was placed on to a specially 
designed plastic stage and a cover slip was then sited on to the mucosa. The microscope 
was illuminated with a 100 watt mercury arc lamp for epi-illumination fluorescence 
light microscopy. The microscope was equipped with water immersion 10 x and 40 x 
lenses. Images were acquired continuously using a charge-coupled device camera 
(CCD, JVC, Japan), displayed on to a high resolution monitor (Iiyama, Japan).The 
images were digitised by a video-frame grabber and then passed through to the central 
processing unit of a computer image workstation where they were analysed (Lucia 
image analysis software).
Following 30 min of reperfusion in the IR and IPC groups, or at equivalent time point in 
the sham group, at random 6 animals received fluorescein isothiocyanate (FITC)
(Sigma, UK) labelled RBC (0.5 mL) intravenously in order to assess microvascular 
blood flow in the villi. FITC labelled RBC was prepared according to a modification of 
the method described previously (Zimmerhackl et al.,  1983) (See Appendix 2 ). 
Microscopically, the labelled cells showed a normal biconcave shape similar to native 
red cells. With the aid of FITC-labelled RBC, the following parameters were measured 
(a) mucosal perfusion index (MPI) (b) mean capillary diameter (MCD) and (c) the RBC 
velocity.
To evaluate the leukocyte-endothelial interactions in the mucosal villi, rhodamine 6G 
(0.2mL of 0.01%; Sigma UK) was injected to another 6 animals as a vital dye that stains 
the leukocytes avidly and accumulates in the mitochondria (Dunn et al., 2002).
108The microscopy technique does not allow the entire mucosa to be kept under 
observation, hence two areas were pre-selected in each animal, at a distance from each 
other for detailed surveillance. Recordings were made from these areas every 15 min 
after the administration of the fluorochromes for a period of 2 hours.
4.3.4  Mucosal Perfusion Index (MPI)
Microhemodynamics in the mucosa of the small intestine was evaluated by scanning the 
mucosa with the 10 x lens for semi-quanitative assessment of homogeneity and 
distribution of mucosal perfusion.  15-20 villi were allocated to three grades of perfusion 
(absent, irregular or good perfusion) according to the method described 
previously(Heuser et al., 2000). A villus was considered to be ‘poorly perfused’ when at 
least 3-4 capillaries were not perfused over more than 20 seconds. Only villi without 
any perfusion were assigned to the ‘absent’ group.
The MPI was calculated by the formula:
MPI= (Ng+0.5 Np)/ Nt
where Ng represents the number of well perfused villi, Np the number of poorly 
perfused villi and Nt the total number of villi analyzed. This index equals  1  if all the 
villi are well perfused and 0 if no villus is perfused at all (Fig 4.1).
109Figure 4.1. Villi stained with FITC labelled red cells (lOx magnification).4.3.5 Mean Capillary Diameter (MCD)
The 40x lens was utilised to assess the MCD. Only villi showing perfusion were chosen 
for the assessment of this parameter. 15 capillaries randomized across the capillary 
network were chosen and the mean was then determined by offline analysis by Lucia 
image grabber.
4.3.6 Capillary Red blood cell velocity
RBC velocity was measured by the utilisation of the 40 x lens. 5 capillaries per villus 
were chosen and the velocity was determined by offline frame-to-frame analysis (Fig 
4.2)
4.3.7 Quantification of Leukocyte Adhesion
The number of leukocytes adherent to the endothelium of up to four separate villi in two 
separate areas was determined by online analysis. A leukocyte was considered adherent 
if it do not move or detach from the endothelial lining within an observation period of 
up to 30 seconds. Data are expressed as the number of adherent leukocytes per length of 
villus at each time point. Leukocytes adherent within the blood vessel were often 
difficult to distinguish from those that had migrated to the interstitial space, but were 
still close proximity to the capillaries. Hence, both the groups of stationary leukocytes 
were regarded as adherent (Kalia et al., 2002).
IllFigure 4.2.9 Frame by Frame analysis of measuring red blood cell velocity followed 
staining with red blood cells labelled with FITC.
1124.3.8  Haem Oxygenase Activity Assay
HO activity in ileal microsomal fractions was measured using a spectrophotometric 
assay of bilirubin production as described previously in Chapter 2.6.1.
4.3.9 Western blot analysis
Haem Oxygenase protein was identified using Western blotting as described previously 
in chapter 2.6.2
4.3.10 Histological Investigation
At the end of the reperfusion period, samples of the lungs were removed, fixed in 10 per 
cent neutral buffered formalin and embedded in paraffin; 4pm thick sections were cut 
using a microtome and mounted on slides for H&E staining.
4.3.11 Statistical Analysis
All values are expressed as mean ± standard error of the mean (SEM). Analysis of 
variance (ANOVA) and Bonferroni adjustment for multiple comparisons were used 
unless otherwise stated, where unpaired Student’s t-test was used for statistical analysis 
between groups. P< 0.050 was considered statistically significant.
1134.4  Results
4.4.1 Mucosal Perfusion Index (MPI)
A homogenous microvascular perfusion with almost all villi being well perfused 
throughout the experiment was observed in sham operated animals. The mean MPI at 
the end of 2 hr reperfusion was 0.70 ± 0.04 (Fig 4.3).
In IR injury of the intestine, the mucosal perfusion was significantly decreased with 
many villi showing complete stasis. The mean MPI in the IR group at the end of 2 hr 
reperfusion was 0.40 ± 0.03 (p<0.05 vs sham). In the IPC group, there was a significant 
increase in the mucosal perfusion compared to IR. The MPI in IPC at the end of 2 hr 
reperfusion was 0.66 ± 0.04 (p<0.05 vs IR ; p >0.05 vs sham).There was complete 
absence of area of non-perfused villi (stasis).
4.4.3  Mean Capillary Diameter (MCD)
Fig 4.4 shows the trend in MCD during reperfusion in all the three groups. In sham 
operated animals the MCD at 15 min of virtual reperfusion point was 6.55 ± 0.80pm 
and was 6.80 ± 0.73pm at the end of the equivalent 2 hr reperfusion period. IR injury 
increased the MCD by 33% compared to sham reaching a value of 9.07 ± 0.56pm at 15 
min of reperfusion. With reperfusion in IR group, MCD increased to 10.16 ± 0.12 pm at 
the end of the 2 hr reperfusion period. This increase of the capillary diameter in IR 
group from the start to the end of reperfusion coincided with the development of 
microvascular stasis. In the IPC group the mean capillary diameter at the end of 15 min 
of reperfusion was 6.94 ± 0.16 pm. However this was not significant compared to both 
sham and IR groups at this time point (p>0.5). The increase of capillary diameter in IR 
group on comparison to the IPC group reached statistical significance at 75 min ofreperfusion (p<0.05 IR vs. IPC).  At the end of the 2 hr reperfusion period, the mean 
capillary diameter in the IPC group was 8.12 ± 0.34 pm (p<0.05 vs. IR).
4.4.4 Capillary Red Blood Cell Velocity
Fig 4.5 shows the changes in capillary RBC velocity in all the three experimental 
groups. Within the sham operated group the RBC velocity did not differ significantly 
during the experiment. In contrast, in the IR group RBC velocity decreased significantly 
compared with sham (0.25 ± 0.02 mm/s vs.0.60 ± 0.07 mm/s, p<0.001) at 15 min post 
reperfusion. IPC increased the RBC velocity to 0.67 ± 0.07 mm/s during the first 15 min 
of reperfusion and reached a final value of 0.74 ± 0.2 mm/s at the end of the 2 hr 
reperfusion (p<0.001 vs. IR).
4.4.5 Leukocyte Adherence
In sham operated animals only occasional leukocytes were adherent within the 
endothelial lining of the mucosal villi throughout the experimental period (Fig.4.6). IR 
injury of the intestine induced a rapid, sustained and a significant increase in the 
leukocyte adhesion in the endothelium (p<0.01 versus sham; Fig. 4.7). It was observed 
that adherent leukocytes were frequently plugging the capillaries leading to reduced or 
no flow within the villus microcirculation. IPC led to a significant decrease in the 
adhesion of the leukocytes to the endothelium (p<0.01 versus IR).
4..4.6 Haem Oxygenase analysis
115Fig 4.8 depicts the mean ileal HO activity at the end of 2 hr of reperfusion in all the 
three experimental groups. The mean HO activity in the sham group was 409.66 ± 62.95 
pico moles bilirubin/ mg/protein/hr. IPC lead to a two-fold increase of HO activity 
(1651.66 ± 231.92) as compared to IR (842.33 ± 85.12) (p<0.01 IPC vs. IR).Fig 4.9 
shows the expression of HO in all the three groups as shown by western blot analysis.
4.4.7  Histological analysis
IR was associated with alveolar damage and neutrophilic infiltration in the lungs, 
whereas IPC attenuated this effect (Fig 4.10)
116Sham IPC
Figure 4.3. Homogeneity of perfusion in the mucosal villi expressed by mucosal 
perfusion index at the end of 2 hr reperfusion. For assessment of the perfusion pattern 
all villi were counted and divided into three groups according to quality of perfusion 
well, irregular and non-perfused.
Results are presented as mean ± SEM. (* p<0.01  vs IR; # p>0.05 vs sham).
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Figure 4.4. Mean Capillary diameter in all the three groups during the period of 
reperfusion. Results are presented as mean ± SEM of 6 animals from each group 
(*p<0.05 versus IR; **p<0.001 vs IR).
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Figure 4.5.10. Red Blood cell velocity in all the three groups during the period of 
reperfusion. Results are presented as mean ± SEM of 6 animals from each group 
(*p<0.05 versus IR; **p<0.001 vs IR).
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Figure 4.6. Leukocyte adherence in (A) sham, (B) IR injury and (C) IPC groups.
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Figure 4.7. Number of adherent leukocytes in the capillary endothelium in all the three
0  _
groups  (cells/  mnr).  Results  are  presented  as  mean  ±  SEM  of 6  animals  from  each
group.(*p<0.01  versus IR ; **p<0.001 vs. IR)
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Figure 4.8. Ileal HO activity in all the three experimental groups at the end of 2 hr of 
reperfusion. (*p<0.01 IPC vs. IR; # p <0.01  sham vs. IR)
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Figure 4.9.  HO expression in all the three groups by western blot analysis.
123Figure 4.10.11. Representative photomicrographs of the lungs (A) in sham operated 
animals (B) subjected to 30 min of ischaemia and 2 hr reperfusion (IR) (C) subjected to 
IPC + IR. (H&E, original magnification x  100).
1244.5 Discussion
To our knowledge this is the first study investigating the microvascular dynamics of 
both red and white blood cells in the intestinal mucosa following IPC. Although, Kubes 
et al showed that IPC of the feline intestine attenuated leukocyte adhesion in the 
mesenteric venules, changes in the mucosa were not addressed in this study (Kubes et 
al.,  1998). The mucosa of the small bowel is exceedingly sensitive to IR injury and even 
a short episode of ischaemia can induce substantial damage to the layer (Mallick et al., 
2004). The tissue damage in IR injury of the intestine is preferentially localized to the 
mucosa with the underlying submucosal layers virtually unaffected and hence it is vital 
to observe the changes in the mucosa. IR injury of the intestine was associated with 
decreased mucosal perfusion index, RBC velocity and increased leukocyte endothelial 
interactions in the mucosa. Our study has clearly demonstrated that IPC attenuates the 
microvascular disturbances by improving the mucosal perfusion index, RBC velocity 
and reduces the adhesion of leukocytes to the endothelium in the mucosal villi of small 
bowel mucosa following IR injury. IPC also preserved the mucosal villous architecture. 
These protective effects were clearly accompanied by a marked expression of HO.
The pathogenesis of cellular damage and microvascular damage following IR injury has 
yet to be fully elucidated. However, increased production of inflammatory mediators, 
decreased blood flow and vascular stasis are all implicated (Gonzalez et al.,  1994). 
Recent studies have shown that induction of HO helps to ameliorate tissue injury or 
inflammatory changes in a variety of experimental models (Attuwaybi et al., 
2004;Tamion et al., 2002). However these studies do not address the role of HO in the 
intestinal microcirculation.
125Capillary no-reflow and leukocyte endothelial interaction hallmark IR injury of the 
intestine(Kaminski and Proctor,  1989). Following IR injury, many cell types may be 
damaged by oxygen free radicals with RBC one of the most vulnerable (Chien, 1982). 
Impaired antioxidant defenses or increased production of oxygen free radicals may 
disturb the critical balance and result in oxidative damage to the RBC (Claster et al., 
1984). Injury to RBC is manifested both morphologically and physiologically (Chien, 
1982). Since damaged RBC tend to increase their deformity and aggregate, the RBC 
velocity may decrease as demonstrated in this study. In addition, RBC lysis may occur, 
both within the capillary lumen and in the extracellular space, thereby releasing a source 
of free haem which may further exacerbate IR injury.
The results of the present study clearly demonstrate that IPC induced maintenance of 
adequate capillary perfusion in vivo, and indicate that the protective effect of the IPC 
phenomenon may be mediated by the action of HO, which catalyzes the conversion of 
haem to carbon monoxide (CO), biliverdin and free iron. CO and its action on capillary 
pericytes may play a major role in this protection. It is well known that capillaries are 
associated abluminally with pericytes which protrude primary cytoplasmic processes 
running along the axes of the capillaries (Hirschi and D'Amore,  1996). From these 
primary processes, lateral processes arise, which completely encircle the capillaries and 
form tight connections to the endothelial cells (Hirschi and D'Amore,  1996).These 
pericytes contain muscle cytoskeletal proteins, in particular a-smooth muscle actin 
which regulate microvascular blood flow (Hirschi and D'Amore,  1996). In vivo studies 
of liver tissue have shown that Ito cells, which are the sinusoid (liver capillary) 
associated pericytes, are primarily responsible for CO mediated blood flow regulation in 
sinusoids (Suematsu et al.,  1996).In addition, there is increasing evidence that CO 
inhibits the aggregation of platelets (Brune and Ullrich, 1987), which could result in
126higher red blood cell velocity because of unhindered flow. Hence tissue viability 
increases because of improved nutritional supply and better elimination of toxic 
residues of oxidative stress. In a recent study Nakao et al demonstrated that inhalation 
of CO ameliorates IR injury in a model of bowel transplantation (Nakao et al., 2003).
Biliverdin is subject to further degradation to bilirubin by the cytosolic enzyme 
biliverdin reductase (Maines,  1988). It acts as an antioxidant and is capable of 
scavenging oxygen free radicals that are thought to be primarily responsible for the 
tissue injury (Stocker et al.,  1987). Iron, the last product of haem breakdown, acts as an 
oxidant like other transition metals and catalyzes the formation of reactive hydroxyl 
radicals (OH*) by the Haber-Weiss reaction. Typically the OH* causes biological 
damage by stimulating the free chain reaction known as lipid peroxidation, in which 
OH* attacks the fatty acid side chains of the membrane phospholipids and causes 
organelle and cell disruption (Halliwell and Gutteridge, 1999). Therefore it seems to be 
of paramount importance to eliminate free iron from the tissue in order to maintain the 
cellular integrity after the stress event. To enable this process, an additional expression 
of ferritin, the iron-binding protein, is induced simultaneously by HO (Bauer and Bauer, 
2002).
In IR injury it was observed that adherent leukocytes were frequently plugging the 
capillaries leading to reduced or no flow within the villus microcirculation. Hayashi et 
al. demonstrated that overexpression of HO-1 in microvascular endothelial cells 
ameliorates oxidative injury and reduced the leukocyte endothelial interactions (Hayashi 
et al.,  1999).Hence, reduction of the leukocyte endothelial interaction by expression of 
HO-1 would reduce the plugging of the capillaries and thereby improve microvascular 
flow.
127The profound effects on the lungs following IR injury of the intestine may be induced 
by the activation of neutrophils following translocation of bacterial endotoxins (Foulds 
et al., 1997). It is possible that the increased mucosal permeability following ischaemia 
allows passive diffusion of endotoxin, which is a potent activator of neutrophils and 
could subsequently lead to remote multiple organ injury.
This study has shown that IR injury of the intestine induces rapid microcirculatory 
breakdown in addition to leukocyte adhesion in the mucosal layer with severe 
pathologic consequences. IPC of the intestine can maintain a functioning mucosal 
microcirculation and markedly attenuate the IR injury. IPC also attenuated the IR 
induced pulmonary injury.
128Chapter 5 Pyrrolidine dithiocarbamate reduces ischaemia reperfusion injury of 
the small intestine
1295.1. Introduction
In the previous chapter it was demonstrated that ischaemic preconditioning (IPC) 
induces the expression of haem oxygenase-1 and thereby alleviates ischaemia 
reperfusion (IR) injury. In this chapter we explore if pharmacological preconditioning 
(drugs that mimic IPC) can protect the small bowel from IR injury.
Therapeutic strategies aimed at ameliorating IR injury have focused both on preventing 
the effects of reactive oxygen species and on downregulating the signal transduction 
cascades related to the expression of proinflammatory genes. Pharmacologic 
preconditioning based on enhancing the production or activity of endogenous protective 
molecules has also been proposed as an alternative therapeutic intervention. Among 
such agents, pyrrolidine dithiocarbamate (PDTC) has a variety of biochemical activities, 
such as redox state alternation, chelation of heavy metals and enzyme inhibition 
(Tsuchihashi et al., 2003). PDTC was initially regarded as a potent inhibitor of nuclear 
factor- kappa B (NF-kB) and used as an antioxidant compound to counteract the toxic 
effects of free radicals (Liu et al.,  1999). PDTC is one of the most effective inducers of 
haem oxygenase-1 (HO-1), which also confers cytoprotection against oxidative stress 
(Hartsfield etal.,  1998).
To the best of our knowledge there are no previous studies exploring the effect of PDTC 
on IR injury of the intestine. Therefore, our study was designed to examine whether 
PDTC preconditioning induces HO expression in small intestine and reduces the 
inflammatory response during reperfusion by focussing on the intestinal microvascular 
perfusion and oxygenation.
1305.3  Materials and Methods
5.3.1 Operative procedures
Animals were anaesthetised and prepared for laparotomy as described in previous 
chapter  2.1.1.
5.3.2 Experimental design
Rats were randomly allocated to 4 study groups (n=6/group).
Group 1.  Sham laparotomy, the SMA was identified and passage of vicryl suture was 
performed, but without vascular occlusion.
Group 2.  IR, the SMA was clamped for 30 min, followed by a 2 hour period of 
reperfusion.
Group 3. PDTC+IR. Animals received a single dose of 100 mg/kg of PDTC (Sigma 
Chemical Co, St Loius, Mo, USA) intramuscularly 30 min before IR.
Group 4. (ZnPP+ PDTC+ IR). ZnPP (Sigma Chemical Co, St Loius, Mo, USA) was 
dissolved in 0.2 mol/L sodium hydroxide and diluted in 0.9% sodium chloride. The 
dose of ZnPP was selected according to the experiment described by 
Tsuchihashi.(Tsuchihashi et al., 2003) Animals received a single dose of 1.5mg/Kg of 
Zinc Protoporphyrin (HO inhibitor) given subcutaneously 30 min before PDTC 
administration.
5.3.3 Measurement of intestinal microvascular perfusion
Intestinal microvascular perfusion was measured by a surface laser Doppler flowmeter 
(LDF) (DRT4, Moor Instruments Limited, Axminster, UK) as described in chapter 3.
1315.3.4 Measurement of intestinal tissue oxygenation
Intestinal tissue oxygenation was measured using NIRS as described in chapter 3.
5.3.5 Measurement of portal venous blood flow
We studied the effect of IR injury and PDTC on the portal venous blood flow (PVF). It 
was monitored continuously as described previously in chapter 3.3.5.
5.3.6 Haem Oxygenase Assay
HO activity in ileal microsomal fractions was measured as described previously in 
chapter 2.6.1.
5.3.7 Biochemical Assays
Blood samples were taken at the end of the experiments from the carotid artery. They 
were centrifuged at 2000 g for 10 min at room temperature to sediment the erythrocytes. 
The serum was removed and analysed on a Hitachi 747 auto-analyzer (Hitachi Ltd, 
Tokyo, Japan) by using commercially available enzymatic kits (Boehringer Mannheim 
Ltd., East Sussex,UK) for lactate dehydrogenase (LDH), aspartate aminotransferase 
(AST) and alanine aminotransferase (ALT).
5.3.8 Histological Investigation
At the end of the experiment, tissue samples of ileum were obtained as described 
previously in chapter 2.7 Ileal injury was assessed by a scoring system devised by Chiu 
et al under light microscopy without knowledge of study groups(Chiu et a l,  1970).
1325.3.9  Data collection and statistical analysis
Data from the pulse oximeter, pressure transducer and LDF were fed into a laptop 
computer and collected continuously at a sampling rate of 2 Hz. The data were 
calculated as 1-min averages at baseline and every 30 min till the end of the experiment. 
All values are expressed as mean ± standard error of the mean (SEM). ANOVA and 
Bonferroni adjustment for multiple comparisons were used unless otherwise stated, 
where unpaired Student’s r-test was used for statistical analysis between groups. P<
0.05 was considered statistically significant.
5.4 Results
5.4.1 Intestinal microvascular perfusion
IMP did not alter significantly during the course of the experiment in the sham group (p 
>0.05).There were significant differences between IR and PDTC groups in IMP at 30 
min of reperfusion (46.7 ±2.8% in IR vs. 67.3±6.2% in PDTC, p <0.010). The increase 
in IMP persisted till the end of the 2 hr reperfusion period (42.5±2.8 % in IR vs. 69.1 ±
4.5 % in PDTC, p<0.010). ZnPP decreased the IMP to 37.3 ± 2.9 % at the end of 2 hr of 
reperfusion (p<0.010 vs. PDTC) (Fig 5.1).
5.4.2 Intestinal tissue oxygenation
Intestinal tissue oxygenation did not alter significantly during the course of the 
experiment in the sham laparotomy group (Fig 5.2). In IR group, with ischaemia there
133was a significant decrease in HbC>2 and Cyt Ox with concomitant increase in Hb. There 
was a significant decline in Hb02 and Cyt Ox levels following reperfusion compared to 
both the baseline and the ischaemia value.
PDTC was associated with significant increased levels of Hb02 and Cyt Ox 
(p<0.001 IPC vs. IR).The levels of Hb02 increased significantly on reperfusion and this 
increase persisted throughout the reperfusion period. The levels of Hb on reperfusion 
showed an increase from ischaemic levels, however, it was statistically lower compared 
to the IR group. ZnPP was associated with decreased Hb02 and Cyt Ox at the end of 
the reperfusion period. (p<0.001 vs. PDTC).
5.4.3 Portal venous blood flow
PVF was reduced significantly during the period of ischaemia (pcO.OOl vs. baseline). At 
the end of the 2 hr reperfusion period it was improved significantly in PDTC group 
(42±9% vs. 69± 8 %; IR vs. PDTC respectively, p<0.01). ZnPP decreased the PVF to 
36 ± 12 % of the baseline at the end of 2hr reperfusion (p<0.01 vs. PDTC) (Fig 5.3)
5.4.4 HO activity assay
The mean HO activity in the sham group was 409.66 ± 62.95 pico moles bilirubin/ 
mg/protein/hr. PDTC lead to a two-fold increase of HO activity (2085.83 ± 158.65) as 
compared to IR (768.66 ± 103.82) (pcO.OOl PDTC vs. IR). The mean HO activity in the 
ZnPP group was significantly reduced as compared with PDTC group (94.00 ± 18.41) 
(p<0.001 vs. PDTC). (Fig 5.4).
5.4.5 Biochemical analysis
134LDH was significantly reduced (P< 0.001) with PDTC (576.3 ± 98.7) as compared to IR 
(1866.0 ± 267.5) (Fig 5.5). The LDH value in sham group at the end of the reperfusion 
was 335.23 ±77.7.
5.4.6  Histological analysis
IR and ZnPP resulted in a loss of normal mucosal villous pattern with increased 
neutrophils whereas PDTC ameliorated this effect. The mean histological score in IR 
was 3.0 ± 0.2 and with PDTC 1.5 ± 0.2 (# pcO.OOl PDTC vs. IR). The mean 
histological score with ZnPP administration was 3.1 ± 0.3 (f p <0.001 PDTC vs. ZnPP) 
(Fig 5.6).
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Figure 5.1. Intestinal microvascular perfusion (IMP) measured by LDF. For 
comparison, LDF readings were recorded as  100% at baseline. Values are mean ± SEM 
of 6 animals in each group.* p<0.01  PDTC vs. IR; ** pcO.OOl PDTC vs. IR; # p<0.01 
PDTC vs. ZnPP; ## pcO.OOl  PDTC vs. ZnPP)
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Figure 5.2. Intestinal tissue oxygenation as measured by NIRS. (* p<0.05  PDTC vs. 
IR; ** pcO.OOl PDTC vs. IR; # p <0.05 PDTC vs. ZnPP; ## p <0.001  PDTC vs. ZnPP).Sham
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Figure 5.3. Portal venous blood flow measured by Transonic Doppler flow probe. For 
comparison, PVF readings were recorded as  100% at baseline. Values are mean ± SEM 
of 6 animals in each group. (*p<0.01 PDTC vs. IR; # p<0.01 PDTC vs. ZnPP)
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Figure 5.4. Mean HO activity in the four experimental groups.
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Figure 5.5. Serum LDH levels in the four experimental groups at the end of 2 hr period 
of reperfusion.
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Figure 5.6. Mean Histological Scores obtained from the four experimental groups. 
# pcO.OOl PDTC vs. IR; f pcO.OOl  PDTC vs. ZnPP.
1405.5 Discussion
The present study has clearly shown that PDTC improves the small bowel 
microvascular perfusion and oxygenation possibly via increased haem oxygenase 
expression while ameliorating IR injury. Zinc Protoporrphyrin was used to inhibit the 
activity of heme oxygenase.  Serum LDH levels, which was used as marker for 
intestinal injury (Sola et al., 2001), reflected intestinal damage in IR group, whereas 
PDTC decreased these levels. IR injury resulted in villous and crypt damage, which has 
attributed to haemorrhage and necrosis, whereas PDTC ameliorated this effect. These 
results suggest that PDTC protects small bowel from IR injury possibly via HO 
production.
One of the effective approaches for attenuating IR injury is to induce endogenous 
antioxidant genes such as HO-1. PDTC has been shown to be a potent inducer of HO-1  
in many experimental models (Hartsfield et al.,  1998;Tsuchihashi et a l, 2003). Whereas 
increasing evidence suggests that HO-1   induction may mediate cellular protection 
against oxidant injury in both in vitro and in vivo models, the role of HO in the 
intestinal microcirculation is poorly understood. In this study the effects of PDTC 
against IR induced intestinal microcirculatory changes were studied by continuously 
measuring intestinal blood flow by using LDF, which has been used extensively to 
monitor intestinal blood flow in both animals and humans (Thollander et al.,  1997). In 
our study, the comparison of IMP between the groups at different time points shows that 
PDTC increased the IMP in the initial 30 minutes of reperfusion. This suggests that the 
mechanism of pharmacologic preconditioning by PDTC modulating flow in the 
microcirculation is an immediate phenomenon. Therefore, the effect of PDTC is likely 
to involve modulation of immediate microcirculatory events at the level of capillaries
141and postcapillary venules, because these are the primary sites of microcirculatory failure 
induced by IR injury.
The results of the present study clearly demonstrate that PDTC induced maintenance of 
adequate microvascular perfusion and oxygenation in vivo, and indicate that this 
protective effect is mediated by the action of HO, which catalyzes the conversion of 
haem to CO, biliverdin and free iron. Clearly, the administration of ZnPP abolished the 
protective effect of PDTC.
The portal venous flow did not show any sign of recovery to baseline in spite of 
reperfusion in the IR group. Tumage et al. demonstrated that the superior mesenteric 
artery blood flow does not return to normal on reperfusion but remains low in IR 
group(Tumage et al.,  1996). Thus reduced flow through the superior mesenteric vein 
would necessarily reduce portal venous flow. At the end of 2 hr of reperfusion, PDTC 
improved the portal venous flow significantly.
In summary, the study in this chapter has demonstrated that intestinal IR injury induces 
rapid microcirculatory breakdown with tissue damage. Administration of PDTC 
maintains the intestinal microvascular blood flow and oxygenation, and markedly 
attenuates the IR injury. PDTC may be of particular value in preventing IR injury to the 
small intestine and might help to improve the results of small bowel transplantation. 
Intestinal IR injury is also an obligatory component of numerous surgical procedures. 
The results of the present study may therefore prove beneficial in many areas of clinical 
research. Additional studies are clearly warranted to evaluate the clinical efficacy of 
PDTC in the prevention of IR injury of the small intestine.
142Chapter 6 Effects of Pyrrolidine dithiocarbamate on the mucosal villous 
microcirculation following ischaemia reperfusion injury of the intestine
1436.1  Introduction
In the previous chapter we showed that pyrrolidine dithiocarbamate (PDTC) improves 
the intestinal microvascular perfusion and oxygenation and thereby attenuates small 
intestinal IR injury. In this chapter we investigate the effects of PDTC on the small 
bowel microcirculation by focussing on the RBC dynamics and leukocyte endothelial 
interactions. We also examined if PDTC pretreatment on pulmonary tissue injury after 
intestinal I/R had any effect.
6.2  Materials and Methods
Animal care and experimental protocols were performed as described in previous 
chapters.
6.2.1 Operative Procedures
Animals were anesthetized and subjected to laparotomy as described in previous 
chapters.
6.2.2 Experimental Protocol
Rats were randomly allocated to 4 study groups (n= 12/group).
Group  1.  Sham laparotomy, the SMA was identified with no vascular occlusion and 
animals received a single dose of 2mL/ kg of 0.9% normal saline subcutaneously. 
Group 2.  IR, the SMA was occluded for 30 min, followed by a 2 hour period of 
reperfusion.
Group 3. PDTC+IR. Animals received a single dose of 100 mg/kg of PDTC (Sigma 
Chemical Co, St Loius, Mo, USA) dissolved in 0.9% sodium chloride given
144subcutaneously 30 min before IR. The time course and dose of PDTC used were based 
on previous studies by Liu et al (Liu et al.,  1999).
Group 4. (ZnPP+ PDTC+ IR). ZnPP (Sigma Chemical Co, St Loius, Mo, USA) was 
dissolved in 0.2 mol/L sodium hydroxide and diluted in 0.9% sodium chloride. The 
dose of ZnPP was selected according to the experiment described by Tsuchihashi 
(Tsuchihashi et al., 2003). Animals received a single dose of 1.5mg/Kg of ZnPP 
subcutaneously 30 min before PDTC administration.
In each group RBC dynamics were studied on 6 animals and the other 6 animals had 
evaluation of the interactions of leukocyte to the endothelium.
6.2.3 In vivo Fluorescence Microscopy
The animals were placed on the stage of a Nikon custom built microscope and subjected 
to intra vital fluoroscopic examination as described in the previous chapters.
6.2.4 Mucosal Perfusion Index (MPI)
MPI was evaluated as described previously in chapter 4.3.4.
6.2.5 Capillary Red blood cell velocity
RBC velocity was measured as described previously in chapter 4.3.5.
6.2.6 Quantification of Leukocyte Adhesion
145The number of leukocytes adherent to the endothelium of up to four separate villi in two 
separate areas was determined by online analysis as described previously in chapter 
4.3.7.
6.2.6 Western blotting for HO-1
Ileal samples were also analyzed by the western immunoblotting technique as described 
previously.
6.2.7 Biochemical Assays
Blood samples were taken after two hours reperfusion from the carotid artery and 
analyzed as described previously in chapter 3.3.6.
6.2.8 Histological Investigation
At the end of the reperfusion period, samples of were removed, fixed in  10 per cent 
neutral buffered formalin and embedded in paraffin; 4pm thick sections were cut using 
a microtome and mounted on slides for haematoxylin and eosin staining.
6.2.9 Statistical Analysis
All data are expressed as mean ± standard error of mean (SEM) values. ANOVA and 
Bonferroni adjustment for multiple comparisons was used for statistical analysis. 
Unpaired Student’s t test was used for comparison between two groups. P < 0 05 was 
considered statistically significant.
1466.3 Results
6.3.1 Systemic Haemodynamic Parameters
There were no significant changes in HR and SaO: throughout the experiment in all the 
four experimental groups (p>0.1). In sham group, the MABP did not change 
significantly throughout the experiment (p >0.05). Clamping of the SMA was associated 
with a significant increase in MABP. Reperfusion restored MABP to pre-ischemic 
values. However, the MABP did not change significantly during the reperfusion period 
in all the four groups (Table 6.1).
6.3.2 Mucosal Perfusion Index (MPI)
A homogenous microvascular perfusion with almost all villi being well perfused 
throughout the experiment was observed in sham operated animals. The mean MPI at 
the end of 2 hr reperfusion was 0.70 ± 0.04 (Fig 6.1).
In IR injury of the intestine, the mucosal perfusion was significantly decreased with 
many villi showing complete stasis. The mean MPI in the IR group at the end of 2 hr 
reperfusion was 0.40 ± 0.03 (p<0.05 vs. sham). In the PTDC group, there was a 
significant increase in the mucosal perfusion compared to IR. The MPI in PDTC at the 
end of 2 hr reperfusion was 0.68 ± 0.04 (p<0.05 vs. IR; p >0.05 vs. sham).There was 
complete absence of areas of non-perfused villi (stasis). ZnPP was associated with 
decreased mucosal perfusion index of 0.33± 0.04 (p<0.05 vs. PDTC).
6.3.3 Capillary Red Blood Cell Velocity
147Within the sham operated group the RBC velocity did not differ significantly during the 
experiment. On the contrary, in the IR group RBC velocity decreased significantly 
compared with sham (0.25 ± 0.02 mm/s vs.0.60 ± 0.07 mm/s, p<0.001) at  15 min post 
reperfusion. PDTC increased the RBC velocity to 0.71  ± 0.10 mm/s during the first 15 
min of reperfusion and reached a final value of 0.80 ± 0.23 mm/s at the end of the 2 hr 
reperfusion (p<0.05 vs. IR). The administration of ZnPP was associated with decreased 
RBC velocity of 0.27 ± 0.04 mm/ s at the end of the 2 hr reperfusion (p <0.05 vs. 
PDTC).( Fig 6.2)
6.3.4 Leukocyte Adherence
IR injury of the intestine induced a rapid, sustained and a significant increase in the 
leukocyte adhesion in the endothelium (p<0.01  versus sham; Fig.6.3). It was observed 
that adherent leukocytes were frequently plugging the capillaries leading to reduced or 
no flow within the villus microcirculation. PDTC led to a significant decrease in the 
adhesion of the leukocytes to the endothelium (p<0.05 vs. IR). ZnPP administration led 
to increase in the adhesion of leukocytes at the end of 2 hr reperfusion (p<0.05 vs. 
PDTC).
6.3.5 Western blotting for HO-1
The administration of PDTC was associated with increased expression of HO-1  whereas 
ZnPP abolished this effect. (Fig 6.4 A& B).
6.3.6 Lung Histology
148The alveoli were collapsed in IR and ZnPP groups. The capillaries within the 
interstitium were often congested with red blood cells and a marked neutrophilic 
infiltrate was apparent in IR and ZnPP groups, indicating haemorrhage. PDTC 
prevented any injury to the pulmonary tissue and the lung histology was similar to that 
in sham, with numerous distended alveoli with thin flattened and delicate alveolar walls. 
The alveoli were well aerated and few neutrophils were observed within the interstitium 
(Fig 6.5).
149Baseline  30 mins  1 hr  2 hrs
of ischaemia  perfusion  of Reperfusion
Heart rate
Sham 250 ± 5 252 ± 3 240 ±8 230 ± 10
IR 251  ±2 252 ± 2 220 ±4 227 ± 12
PDTC 252 ± 3 251 ±3 240 ± 10 232 ± 7
ZnPP 245± 10 236 ± 5 242 ±8 241 ± 5
>a02
Sham 98 ±2 95 ±2 94 ±3 95 ±2
IR 98 ± 1 95 ±2 97 ±2 95 ±3
PDTC 98 ± 1 96 ±3 93 ± 1 96 ±3
ZnPP 98 ±2 97 ±2 95 ±2 96 ±2
MABP
Sham 83 ±6 76  ±5 74 ±6 78 ±8
IR 90 ±3 108 ±5* 81 ±3 72 ±5
PDTC 87 ±5 107 ±5* 79 ±4 73 ±6
ZnPP 83 ± 3 104 ±2* 82 ±5 76 ±3
Table 6.1. Systemic haemodynamic parameters in all the four groups. Key: HR- Heart 
Rate (in beats per minute); SaO:- arterial oxygen saturation (in  MABP- Mean 
arterial blood pressure (in mm Hg).  * p <0.01  vs. baseline.
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Figure 12.1 Mucosal perfusion index at the end of 2 hr reperfusion in all the four 
experimental groups. For assessment of the perfusion pattern all villi were counted and 
divided into three groups according to quality of perfusion well, irregular and non­
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Figure 6.2. Capillary RBC velocity in all the four groups during the period of 
reperfusion. Results are presented as mean ± SEM of 6 animals from each group 
(*p<0.05 PDTC vs. IR; **p<0.01  PDTC vs. IR; # p<0.05 ZnPP vs. PDTC; ## p<0.01 
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Figure 6.3. Number of adherent leukocytes in the capillary endothelium in all the four 
groups. Results are presented as mean ± SEM of 6 animals from each group.(*p<0.05 
PDTC vs. IR ; **p<0.001  PDTC vs. IR; # p<0.05 ZnPP vs. PDTC; ## p<0.01 ZnPP vs. 
PDTC; t p<0.01  IR vs. Sham; t t  p<0.001).
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154Figure 6.5. Lung histology of animals in (A) sham laparotomy, (B) IR ,(C) PDTC+IR 
and (D) ZnPP groups. Collapsed alveoli, thickened interstitial walls, and a dense 
neutrophilic infiltrate were observed in untreated intestinal IR and ZnPP animals. 
However, relatively normal histology, with numerous alveoli and thin alveolar walls, 
was observed in PDTC pretreated IR animals.
1556.5 Discussion
Gut ischaemia and mucosal injury have been proposed to play a role in the development 
and maintenance of the systemic inflammatory response, a key factor causing multiple 
organ failure (Pastores et al.,  1996). Our study has clearly demonstrated that PDTC 
attenuates the microvascular disturbances by improving the mucosal perfusion index, 
RBC velocity and reduces the adhesion of leukocytes to the endothelium in the mucosal 
villi of small bowel mucosa following IR injury. PDTC also attenuated IR induced 
pulmonary tissue injury. These protective effects were clearly associated by the 
increased of HO-1  and abolished by the administration of ZnPP, a potent inhibitor of 
HO-1.
Our results also indicate that HO activity was increased in the IR group on comparison 
to the sham group. These results are similar to the findings of Patel et al. (Patel et al., 
2004). Previous studies also demonstrate HO expression is controlled at the level of 
gene transcription (Lee et al.,  1997;Ohlmann et al., 2003). The probable explanation for 
the increase in IR group is that, hypoxia is well known to induce the expression of HO, 
ischaemia probably stimulates HO but mRNA synthesis is limited by the energy- 
depleted state of the cell. However, during reperfusion, cellular ATP pools are revived, 
thus enabling HO mRNA synthesis
The profound effects on the lungs following IR injury of the intestine may be induced 
by the activation of neutrophils following translocation of bacterial endotoxins. It is 
possible that the increased mucosal permeability following ischaemia allows passive
156diffusion of endotoxin, which is a potent activator of neutrophils and could 
subsequently lead to remote multiple organ injury (Foulds et a l 1997).
1576.5 Conclusions
This chapter has shown that IR injury of the intestine induces rapid microcirculatory 
breakdown in addition to leukocyte adhesion in the mucosal layer with severe localized 
and systemic consequences. The administration of PDTC maintained a functioning 
mucosal microcirculation and markedly attenuated the IR injury. Thereby, PDTC may 
prove a prophylactic or therapeutic option to support the integrity of the gastrointestinal 
mucosa and to preserve or restore its barrier function. This may reduce translocation of 
toxins from the gastrointestinal lumen and consequently reduce the onset or severity of 
multiple organ failure.
158Chapter 7 Haem oxygenase mediates microvascular protection in the late phase of 
ischaemia reperfusion injury of the intestine
1597.1 Introduction
In the previous chapters it was shown that ischaemic preconditioning (IPC) and 
pharmacologic preconditioning with pyrrolidine dithiocarbamate (PDTC) protects the 
small bowel against ischaemia reperfusion (IR) injury of the intestine in the early phase 
(following 2hr ) of reperfusion injury. This protection was afforded by the expression of 
haem oxygenase-1   (HO-1). In this chapter, the role of ischaemic and pharmacologic 
preconditioning in the late phase (following 24 hr) is examined.
The effects of IPC can be differentiated into two phases characterized by different time 
frames and mechanisms: (a) an early phase (early or classic preconditioning), that 
immediately follows the transient ischaemia and lasts 2-3 hr and (2) a late phase (late 
preconditioning), which begins  12-24 hr from the transient ischaemia and lasts for 
about 3-4 days(Mallick et al., 2004).
7.2 Materials and Methods
Animal care and experimental protocols were performed in accordance with the Home 
Office Guidance in the Operation of the Animals (Scientific Procedures) Act  1986.
Male Sprague-Dawley rats weighing 250- 300g were used in this study. Rats were kept 
in temperature controlled environment with  12 hours light- dark cycle and allowed tap 
water and standard rat chow pellets ad libitum.
7.2.1  Operative Procedures
Animals were anesthetized using isoflurane (Baxter, Norfolk, UK) and allowed to 
breathe spontaneously via concentric mask connected to an oxygen regulator. The
160animal’s body temperature was maintained at 36-38 °C using a heating pad (Harvard 
apparatus Ltd., Kent, UK) and monitored with a rectal temperature probe. The arterial 
oxygen saturation (SaO^) and heart rate (HR) were continuously monitored with a pulse 
oximeter (Ohmeda Biox 3740 pulse oximeter, Ohmeda Louisville, Colorado, USA). 
Laparotomy was carried out through a midline incision. The superior mesenteric artery 
(SMA) was identified and occluded with a non-traumatic vessel clamp to induce 
ischaemia. Reperfusion started when the clamp was released. Sham animals underwent 
the identical procedure but without placement of a clamp on the SMA. The incision was 
closed, 0.025 mL of subcutaneous carprofen was administrated, and the rats were 
allowed to recover with free access to food and water. 24 hours following ischaemia or 
at equivalent point in the sham group, animals were re-anesthetized for a terminal 
procedure.  Rats were randomly allocated to 5 study groups (n= 12/group). In each group 
RBC dynamics were studied on 6 animals and the other 6 animals had evaluation of the 
interactions of leukocyte to the endothelium.
7.2.2  Experimental Protocol
Group  1.  Sham laparotomy, the SMA was identified with no vascular occlusion and 
animals received a single dose of 2mL/ kg of 0.9% normal saline subcutaneously.
Group 2.  IR, the SMA was occluded for 30 min, followed by 24 hour period of 
reperfusion.
Group 3. IPC,  10 min of ischaemia followed by  10 min of reperfusion + as in Group II 
procedure.
Group 4. PDTC+IR. Animals received a single dose of 100 mg/kg of PDTC (Sigma 
Chemical Co, St Loius, Mo, USA) dissolved in 0.9% sodium chloride given 
subcutaneously 30 min before ischaemia. The time course and dose of PDTC used were 
based on previous studies by Liu et al (Liu et al.,  1999).
161Group 5. (ZnPP+ IPC+ IR). ZnPP (Sigma Chemical Co, St Loius, Mo, USA) was 
dissolved in 0.2 mol/L sodium hydroxide and diluted in 0.9% sodium chloride. The 
dose of ZnPP was selected according to the experiment described by Tsuchihashi et al 
(Tsuchihashi et al., 2003). Animals received a single dose of 1.5mg/Kg of ZnPP given 
subcutaneously 30 min before PDTC administration.  The right jugular vein was 
cannulated with a polyethylene catheter (0.40-mm inner diameter, Portex, Kent, UK) for 
administering fluorochromes. The abdomen was re-opened through the previous 
incision. The ileum was identified and the mucosal surface was exposed in a segment of 
exteriorized ileum by making a 30 mm incision along the anti-mesenteric border using 
an electric microcautery. The animal’s abdomen was covered with a plastic wrap (Saran 
wrap®, Dow Chemical, Michigan, USA) to prevent fluid evaporation.
7.2.3  In vivo Fluorescence Microscopy
The animals were placed on the stage of a Nikon custom built microscope (Nikon, 
Japan) as described previously.
Following 24 hrs of reperfusion, 6 animals received rhodamine 6G (0.2mL of 0.01%; 
Sigma UK) and other 6 received fluorescein isothiocyanate (FITC) (Sigma, UK) 
labelled RBC (0.5 mL) as a bolus injection from each group into the jugular vein.The 
dyes were prepared as described in the previous chapters. The following parameters 
were measured (a) mucosal perfusion index (MPI) and (b) RBC velocity on 
administration of FITC-labelled RBC
Rhodamine 6G evaluated the leukocyte-endothelial interactions in the mucosal villi 
(Dunn et al., 2002).
162The microscopy technique does not allow the entire mucosa to be kept under 
observation, hence two areas were pre-selected in each animal, at a distance from each 
other for detailed surveillance. Recordings were made from these areas every  10 min 
after the administration of the fluorochromes for a period of 30 minutes.
7.2.4 Mucosal Perfusion Index (MPI)
MP1 was evaluated as described previously in chapter 4.3.4.
7.2.5 Mean Capillary Diameter (MCD)
The 40x lens was utilised to assess the MCD. Only villi showing perfusion were chosen 
for the assessment of this parameter. 15 capillaries randomized across the capillary 
network were chosen and the mean was then determined by offline analysis by Lucia 
image grabber.
7.2.6 Capillary Red blood cell velocity
RBC velocity was measured as described previously in chapter 4.3.5.
7.2.7 Quantification of Leukocyte Adhesion
The number of leukocytes adherent to the endothelium of up to four separate villi in two 
separate areas was determined as described in chapter 4.3.6.
1637.2.8  Haem Oxygenase Activity Assay
HO activity in ileal microsomal fractions was measured using a spectrophotometric 
assay of bilirubin production as described in the previous chapters.
7.2.9 Western blotting for HO-1
Ileal samples were also analyzed by the western immunoblotting technique as described 
in the previous chapters.
7.2.10 Biochemical Assays
Blood samples were taken from the inferior vena cava following 24 hr of reperfusion. 
The analysis of blood samples was performed as described previously in chapter 3.3.6.
7.2.11 Histological Investigations
At the end of the reperfusion period, samples of ileum and lungs were removed and 
analyzed for histological assessment as described previously.
7.2.12 Data Collection and statistical analysis
All data are expressed as mean ± standard error of mean (SEM) values. ANOVA and 
Bonferroni adjustment for multiple comparisons was used for statistical analysis. 
Unpaired Student’s t test was used for comparison between two groups. P < 0 05 was 
considered statistically significant.
1647.3 Results
7.3.1 Mucosal Perfusion Index (MPI)
A homogenous microvascular perfusion with most of the villi being well perfused 
throughout the experiment was observed in sham operated animals. The mean MPI at 
the end of 24 hr reperfusion was 0.76 ± 0.04 (Fig 7.1).
In IR injury of the intestine, the mucosal perfusion was significantly decreased with 
many villi showing complete stasis. The mean MPI in the IR group at the end of 24 hr 
reperfusion was 0.36 ± 0.04 (p<0.001  vs. sham). In the IPC group, there was a 
significant increase in the mucosal perfusion compared to IR. The MPI in IPC at the end 
of 24 hr reperfusion was 0.68 ± 0.04 (p<0.001  vs. IR; p >0.05 vs. sham). PDTC led to 
an increase in MPI at the end of the 24 hr reperfusion and the mean value was 0.65± 
0.04 (p <0.001  vs. IR). ZnPP led to a decrease in the MPI of 0.45± 0.08 (p >0.05 vs. IR; 
p<0.001  vs. PDTC and IPC).
7.4.2 Mean Capillary Diameter (MCD)
At the end of the reperfusion, the MCD in the sham operated animals was 7.43 ± 0.29. 
The MCD in IPC group was 6.49± 0.27 and in PDTC group it was 6.24± 0.36. IR and 
ZnPP led to an increase of MPI (11.75± 4.35 in IR and 8.81 ±2.42 in ZnPP), though this 
increase was not significant on comparison to IPC, sham and PDTC groups. (p>0.05) 
(Fig.  7.2)
7.4.3 Capillary Red blood cell Velocity
165In the IR group RBC velocity decreased significantly compared with sham (0.17 ± 0.04 
mm/s vs.0.36 ± 0.07 mm/s, p<0.05). IPC increased the RBC velocity to 0.38 ± 0.08 
mm/s (p<0.05 vs. IR). The administration of PDTC improved the RBC velocity (0.34 ± 
0.03 mm/s, p<0.05 vs. IR). ZnPP was associated with decreased RBC velocity of 0.11  ± 
0.03 mm/ s (p <0.05 vs. PDTC) (Fig. 7.3).
7.4.3 Leukocyte Adherence
In sham operated animals only a few leukocytes were found to be adherent within the 
endothelial lining of the mucosal villi (4.50 ± 1.56 cells/ length of villus). IR injury of 
the intestine induced a significant increase in the leukocyte adhesion in the endothelium 
(23.33 ± 2.27 cells/ length of villus; p<0.01  versus sham; Fig.7.4). It was observed that 
adherent leukocytes were frequently plugging the capillaries leading to reduced or no 
flow within the villus microcirculation. IPC led to a significant decrease in the adhesion 
of the leukocytes to the endothelium (8.33 ± 2.45 cells/ length of villus p<0.001  vs. IR). 
ZnPP administration led to increase in the adhesion of leukocytes (16.83 ±  1.72 cells/ 
length of villus; p<0.01  vs. IPC), whereas PDTC administration significantly decreased 
the leukocyte adhesion in the endothelium (5.83±  1.16 cells/ length of villus; p< 0.01 
vs. IR).
7.4.4 Haem Oxygenase activity and Western blot for HO-1
Fig.  7.5 depicts the mean ileal HO activity at the end of  the reperfusion in all the five 
experimental groups in pico moles bilirubin/ mg/protein/hr. IR led to an increase of 
mean HO activity as compared to  the sham group (p<0.001). IPC led to more than two­
fold increase of HO activity (1719.25 ± 273.10) as compared to IR (708.01  ± 311.46) 
(p<0.001  vs. IR). The mean HO activity in PDTC group was  1462.91  ± 254.45 (p
166<0.001  vs. IR). The mean HO activity in the ZnPP group was  173.56 ±61.05 (p<0.001 
vs. PDTC). Fig 7.6 shows IPC induces the expression of HO-1 by western blotting.
7.4.5 Biochemical Assays
Fig 7.7 shows the LDH levels at the end of the reperfusion in all the five groups. The 
LDH value in sham group at the end of the reperfusion was 378 .33 ± 113.6 U/L. LDH 
was significantly reduced (P< 0.001) in IPC (587.5 ± 174.0 U/L) as compared to IR 
(1548.8 ± 301.2 U/L). PDTC reduced the LDH levels as compared to ZnPP. (428.0 ±
111.6 U/L vs.  1673.5 ± 480.4 (p<0.001).
7.4.6 Intestinal histology
After 24 hrs of reperfusion, disruption of mucosal villous architecture was observed in 
IR group. However, IPC and PDTC well preserved the mucosal pattern. ZnPP led to 
damage to the mucosal layer with necrosis (Fig 7.8).
1A J Lung Histology
Following IR and with the administration of ZnPP, it was noted that the pulmonary 
alveoli were either collapsed or not distended to the same degree as in sham. (Fig 7.9) 
IR and ZnPP groups were associated with marked neutrophilic infiltration in the 
capillaries within the interstitium. IPC and PDTC attenuated injury to the pulmonary 
tissue with the alveoli being well aerated and few neutrophils.
1670.0
Sham  IR  IPC  PDTC  ZnPP
Figure 7.1. The mucosal perfusion index in all the five experimental groups.(* p<0.001
IPC vs. IR; # p<0.001 PDTC vs. IR; t p<0.001 PDTC vs. ZnPP)
P<0.01 P<0.01
Sham  IR  IPC  PDTC  ZnPP
Figure 7.2. Mean capillary diameter in all the five experimental groups (NS- non­
significant).
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Figure 7.3 The red blood cell velocity in all the five experimental groups (*p<0.05 IPC 
vs. IR; # p<0.05 PDTC vs. IR; t  PDTC vs. ZnPP)
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Figure 7.4 Leukocyte adhesion in all the five experimental groups.
P<0.01
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Sham  IR  IPC  PDTC
Figure 7.5.  Mean HO activity in all the Five experimental groups.
ZnPP1   2  3  4  5
Lanes :  1. IR 2. IPC  3. PDTC  4. ZnPP  5. Sham
Figure 7.6 The expression of HO-1  at the end of 24 hrs of reperfusion detected by 
western blotting.
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Figure 7.7 Mean serum LDH levels in the five experimental groups.
172Figure 7.8 Representative histologic sections in the five experimental groups. IPC and 
PDTC preserved the mucosal villous pattern whereas IR and ZnPP led to mucosal 
necrosis.
173Figure 7.9 Representative lung histologic specimens from the Five experimental groups.
1747.5 Discussion
This chapter investigated the late effects of ischaemic preconditioning (IPC) on the 
intestinal microcirculation and how it relates to HO metabolism. The experimental 
model of 30 minutes of ischaemia with 24 hours reperfusion had no procedure-related 
mortality and was developed to evaluate intestinal injury in the late phase (24 hours) of 
reperfusion after substantial but non-lethal ischaemia.
In this study, to evaluate the effect of HO-1  on the intestinal microcirculation, additional 
groups had Pyrrolidine dithiocarbamate (PDTC) (HO-1 donor) and Zinc 
Protoporrphyrin (inhibitor of HO-1) administered before IR injury. The results of this 
chapter indicate that the beneficial effect of preconditioning could be related to an 
improvement in microcirculation and implicates HO-1  as a contributory mechanism. 
PDTC treatment protected against IR injury similar to preconditioning, whereas ZnPP 
administration aggravated microcirculatory impairment and cellular injury in 
preconditioned animals.
The results of the present study clearly demonstrate that PDTC treatment before IR 
resulted in significant improvement in intestinal microvascular perfusion and 
attenuation of leukocyte-endothelial interactions when compared with IR group. This 
suggests that mechanism modulated by IPC involve HO-1 production as shown by the 
increase of HO-1 expression. In contrast, the use of HO-1  synthesis inhibitor ZnPP with 
IPC in this study led to the derangement of the intestinal microcirculation as shown by 
decreased perfusion and increased leukocyte accumulation in the villi. Therefore HO-1 
inhibition promotes leukocyte adhesion and has decreases intestinal microvascular 
perfusion. The results of this study also show that both IPC and PDTC treatment 
resulted in increased expression of HO-1, whereas administration of ZnPP resulted in
175significant reductions in the expression of HO-1  indicating effective inhibition of HO-1. 
IR and ZnPP was associated with an increase of the capillary diameter which indicated 
the development of microvascular stasis.
This study has shown that IR injury of the intestine induces rapid microcirculatory 
breakdown in addition to leukocyte adhesion in the mucosal layer with severe 
pathologic consequences. IPC of the intestine can maintain a functioning mucosal 
microcirculation and markedly attenuate the IR injury. Thus, the data from this study 
emphasize the association of HO-1  with IR induced intestinal injury and suggest a 
positive relationship between IPC and the improvement in intestinal microcirculation 
and reduction in intestinal injury. The data from this study also suggest that HO-1  limits 
the progression of IR injury and inhibition of HO-1  synthesis blocks the preconditioning 
effect and exacerbates intestinal injury. These observations provide evidence that HO-1 
is strongly associated with the preconditioning effect and may be an important factor in 
mediating the preconditioning response.
176Chapter 8 Summary of the thesis
1778.1 Summary
To our knowledge this is the first study investigating the tissue oxygenation and 
microdynamics of both red and white blood cells in the intestinal mucosa following IPC 
in the early and late phase of IR injury. Previously, Kubes et al showed that IPC of the 
feline intestine attenuated leukocyte adhesion in the mesenteric venules, changes in the 
mucosa were not addressed in this study (Kubes et al.,  1998). The mucosa of the small 
bowel is exceedingly sensitive to IR injury and even a short episode of ischaemia can 
induce substantial damage to the layer (Mallick et al.y  2004). The tissue damage in IR 
injury of the intestine is preferentially localized to the mucosa with the underlying 
submucosal layers virtually unaffected and hence it is vital to observe the changes in the 
mucosa. IR injury of the intestine was associated with decreased mucosal perfusion 
index, RBC velocity and increased leukocyte endothelial interactions in the mucosa.
The increase in leukocyte-endothelial interactions was in concordance with the studies 
by Kalia et al (Kalia et al., 2002). Our study has clearly demonstrated that IPC 
attenuates the microvascular disturbances by improving the mucosal perfusion index, 
RBC velocity and reduces the adhesion of leukocytes to the endothelium in the mucosal 
villi of small bowel mucosa following both early and late phases of IR injury. IPC also 
preserved the mucosal villous architecture. These protective effects were clearly 
accompanied by a marked expression of HO.
Recent studies have shown that induction of HO helps to ameliorate tissue injury or 
inflammatory changes in a variety of experimental models (Attuwaybi et al., 
2004;Tamion et al., 2002). However these studies do not address the role of HO in the 
intestinal microcirculation.
178Capillary no-reflow and leukocyte endothelial interaction hallmark IR injury of the 
intestine(Kaminski and Proctor,  1989). Following IR injury, many cell types may be 
damaged by oxygen free radicals with RBC one of the most vulnerable (Chien,  1982). 
Impaired antioxidant defenses or increased production of oxygen free radicals may 
disturb the critical balance and result in oxidative damage to the RBC (Claster et al., 
1984). Injury to RBC is manifested both morphologically and physiologically (Chien, 
1982). Since damaged RBC tend to increase their deformity and aggregate, the RBC 
velocity may decrease as demonstrated in this study. In addition, RBC lysis may occur, 
both within the capillary lumen and in the extracellular space, thereby releasing a source 
of free haem which may further exacerbate IR injury.
The results of the present study clearly demonstrate that IPC induced maintenance of 
adequate capillary perfusion in vivo, and indicate that the protective effect of the IPC 
phenomenon may be mediated by the action of HO as shown by western blot analysis.
In IR injury it was observed that adherent leukocytes were frequently plugging the 
capillaries leading to reduced or no flow within the villus microcirculation. Hayashi et 
al. demonstrated that overexpression of HO-1   in microvascular endothelial cells 
ameliorates oxidative injury and reduced the leukocyte endothelial interactions (Hayashi 
et al.,  1999).Hence, reduction of the leukocyte endothelial interaction by expression of 
HO-1   would reduce the plugging of the capillaries and thereby improve microvascular 
flow.
The profound effects on the lungs following IR injury of the intestine may be induced 
by the activation of neutrophils following translocation of bacterial endotoxins (Foulds 
et al.,  1997). It is possible that the increased mucosal permeability following ischaemia
179allows passive diffusion of endotoxin, which is a potent activator of neutrophils and 
could subsequently lead to remote multiple organ injury.
This study has shown that IR injury of the intestine induces rapid microcirculatory 
breakdown in addition to leukocyte adhesion in the mucosal layer with severe 
pathologic consequences. IPC of the intestine can maintain a functioning mucosal 
microcirculation and markedly attenuate the IR injury. IPC also attenuated the IR 
induced pulmonary injury.
1808.2 Methodological considerations
8.2.1  The Experimental model
The study of the cascade of phenomena related to ischaemia and reperfusion in the 
intestine is of particular interest due to the importance of ischaemia in abdominal and 
cardiac surgery, shock and small bowel transplantation. Ischaemia reperfusion injury of 
the intestine is inevitable following small bowel transplantation. The complexity of the 
intestinal microcirculation is also a major obstacle to reproduce and analyse 
pathophysiological mechanisms under experimental conditions.
The experimental model employed in this study offered the opportunity of assessment 
of both haemodynamic and microcirculatory parameters in the rat intestine, both under 
normal conditions and also when it is submitted to ischaemia and reperfusion.
In contrast with preservation of organs at low temperatures, normothermic ischaemia 
produces rapid injury to the intestine, with the possibility of in-vivo study without the 
systemic effect of transplantation itself, which represents a major disturbance for 
physiological investigations. Normothermic ischaemia of the intestine is, to some 
extent, a simulation of the circulatory and metabolic conditions of transplantation, 
being, nevertheless, a simple, reproducible and efficient experimental method, with low 
mortality and morbidity.
The model is ideal to study the relationship between post ischaemic intestinal blood 
flow and post ischaemic small bowel function. The experimental reproduction of these
181phenomena at others levels is only possible with the application of sophisticated 
methods of isolated perfused organs or cell and tissue cultures.
The rat was selected as the experimental animal due to its resistance to surgical trauma 
and infection, the advantage of size and the intestinal microvascular anatomy which 
makes the technical procedure possible, compared with other laboratory animals.
The rat model of intestinal ischaemia and reperfusion is a useful procedure for the study 
of the local and systemic effects of ischaemia and reperfusion injury. This model offers 
a well defined volume of tissue that can be easily rendered ischaemic with little or no 
alteration of systemic haemodynamics.
In this study, blood flow to the small bowel was interrupted by clamping of the superior 
mesenteric artery. Experimental data suggest that IR induced intestinal injury occurs in 
a biphasic manner; an early phase of injury that develops over the course of 2 h of 
reperfusion and a later progressive phase that develops at 6 to 24 hrs after 
reperfusion(Slavikova et al.,  1998).  Hence 2hr of reperfusion was chosen as the early 
phase of reperfusion injury and 24 hr of reperfusion chosen as the late phase of 
reperfusion injury. The ischaemic times utilized in this study were selected on the basis 
of multiple experiments. This technique of intestinal ischaemia and reperfusion in the 
rat is easily performed and can always be reproduced; the initial ischaemic changes in 
the intestine are evident and leave no doubt of the proper positioning of the clamp. In 
addition, the procedure can be performed rapidly, and there was no procedure related 
mortality.
182The next section addresses the application of various tests to assess the pathophysiology 
of small bowel ischaemia and reperfusion in this in vivo rat model. All the described 
tests are not necessarily applied to every experimental situation; sometimes for being 
redundant, or not applicable to the particular conditions of the experiment, in terms of 
ischaemic times utilized, periods of observation, or peculiarities of the drugs utilized.
8.2.2  Laser Doppler Flowmetry
The estimation of microcirculatory blood flow is of crucial interest for the analysis of 
the events that occur during organ ischaemia and reperfusion. Changes in the tissue 
blood flow of different organs during reperfusion have been described, and in case of 
the small bowel, there is now increasing evidence that impairment of the intestinal 
microcirculation is a major determinant of ischaemia reperfusion injury.
Laser Doppler Flowmetry is a reliable method for the continuous measurement of tissue 
blood flow. LDF has been validated as a method for measuring gastrointestinal 
microvascular blood flow in animal models(Feld et al.,  1982;Shepherd and Riedel, 
1982)and humans(Thollander et al.,  1996). The LDF probe was placed on a Fixed site 
on the serosa of the ileum and was held in place by a probe holder. Serosal blood flow 
has previously been shown to correlate well with mucosal flow(Corbett et al., 2000). 
LDF data were collected continuously at sampling rate of 2Hz on computer.
This method does not measure the microcirculatory blood flow of the small bowel as a 
whole, which would be ideal, however, the location of the probe in a fixed point of the 
intestinal surface throughout the experiment allows the continuous record of the flow 
signal to be considered representative of the microcirculatory changes on that point
183during the different stages of the procedure, using the same place as a control. A 
baseline recording of flow as a standard (100%) was used in each individual 
experiment; nevertheless, the absolute perfusion values in pre-ischaemic, anaesthetized 
rats are rather constant, being around 280 LDF Perfusion Units.
During the application of LDF during the experiments a few problems were 
encountered. The Laser Doppler monitor can produce artifact signals due to vibration or 
other movements of the fibreoptic probe itself and due to relative movements between 
the probe and the explored tissue. In our experimental model it was possible to obtain 
reasonably artifact-free readings with a good level of anaesthesia and leaving the probe 
loosely in contact with the ileal serosa (instead of firmly attached to a manipulator).
The unit measured with the LDF was expressed in arbitrary "Perfusion Units". This is 
because the backscattered light varies from one organ to another depending on factors 
including light absorption and red cell fraction of different tissues and it is not possible 
to translate the values into a unit of flux that can be utilized for different organs; 
nevertheless, when applied to the same organ the signal is reproducible within a narrow 
range of variation.
8.2.3  Near infrared spectroscopy
NIRS is a non-invasive technique to assess intestinal tissue oxygenation. A 
commercially available near infrared spectrophotometer that was developed for 
measurement of brain tissue oxygenation was used(Cope et al.,  1988). An algorithm 
designed specifically to measure intestinal tissue oxygenation was used.
184During the application of NIRS during the experiments few problems were encountered. 
The interference by the effect of operating lights on the measurement requires dimming 
of the operating lights and covering the probes with lightproof black cloth. This could 
represent a minor difficulty in its clinical application. Variation in measurements were 
found with the reapplication of the probes even on the same site of measurement which 
may be caused by variation of the optical properties of the area under investigation 
which are tested and accounted for by the spectroscopy with the initial setting. This 
problem restricts the NIRS application as the probes must be applied and maintained in 
the same site without movement during the whole procedure, which may be impractical 
in clinical situation. Absolute quantification of the measurement will solve such 
problem.
The volume of blood changes during ischemia and reperfusion may affect the amount of 
light scattering. In theory, this may influence both NIRS as well as LDF measurements. 
As far as we know there are no reports of studies investigating the relationship between 
changes in light scattering and changes in blood volume in the rat small bowel in the 
context of ischaemia and reperfusion. In the brain for example, large changes in the 
cerebral energy state do not cause large changes in light scattering in hypoxic-ischaemic 
piglet brains. An assumption was made that the observed optical density changes are 
caused by altered chromophore absorbance and not light scattering. To determine 
absolute changes in chromophore concentration, the optical path length in the tissue 
must be known as a function of wavelength. The differential path length factor has been 
determined specifically for the small bowel by measuring the absorption coefficient as a 
function of wavelength. The differential path length factor of the small bowel is 2.7, and
185this value was used to adjust the NIRS algorithm for calculating the changes in the 
chromophore concentration.
8.2.4  In vivo fluorescent microscopy
The term in vivo microscopy summarizes experimental approaches in which the 
microcirculation of organs is made accessible to direct observation. Although direct 
quantitative techniques are difficult to implement in the clinical scenario, nevertheless 
they provide advantages over indirect methods because the microcirculation does not 
respond uniformly to either physiological or pharmacological interventions. In vivo 
microscopy of the intestine allows assessment of the intestinal microvascular perfusion, 
the analysis of dynamic processes such as changes in diameters of blood vessels, 
interactions between leukocytes and endothelium.
For the purposes of in vivo microscopic assessments, a plane organ surface is necessary 
to provide clear and sharp images without inducing trauma to the tissue under the 
objective. The anaesthetized animals were placed on the stage of a Nikon custom built 
microscope (Nikon, Japan) with an integrated heating system where the temperature 
was maintained at 37°C. The whole set up was placed on a pneumatic vibration isolation 
workstation (Newport, USA) to minimise vibration. The mucosal surface was exposed 
in a segment of exteriorized ileum by making a 30 mm incision along the anti- 
mesenteric border using an electric microcautery. The small bowel was placed on to a 
specially designed plastic stage and a cover slip was then sited on to the mucosa.  This 
procedure was easily tolerated by the animals and allowed the tissue to be exteriorized 
with a minimum of trauma. This method of exteriorization of the ileum also eliminated 
the respiratory movements in the tissue. The mucosal surface was kept moist with 
isotonic saline. During the experiments, the animal’s abdomen was covered with a
186plastic wrap (Saran wrap®, Dow Chemical, Michigan, USA) to prevent fluid 
evaporation. The loops of small bowel must be carefully handled, as mechanical trauma 
induces disturbances in microcirculation. Microhaemorrhages falsify the results and can 
make clear observation impossible. In order to obtain clear images, it is necessary to 
match the concentration of fluorescent dyes with the filter systems, the light intensity 
and the magnification.
Evaluation of microcirculatory parameters has to be performed in conjunction with 
findings from the macrocirculation. Arterial blood pressure and heart rate were 
measured during the experiments in order to fulfil this requirement.
We measured the following parameters using the fluorescent dyes: mucosal perfusion, 
capillary diameter, red blood cell velocity and leukocyte-endothelial interactions. 
Evaluation of the microscopic images depends on subjective viewpoints rather than 
absolute values.
8.2.5  Serum Lactate dehydrogenase and liver enzymes
Previous studies have shown that the estimation of serum lactate dehydrogenase (LDH) 
is a very sensitive marker of intestinal ischaemia(Caglayan et al., 2002).  Blood levels 
of intracellular enzymes are a way of estimating tissue damage: tissue or organ specific 
enzyme levels provide valuable information about related tissues. LDH released from 
the damaged intestine during ischaemia enters the circulation during reperfusion and 
their blood levels increase. The addition of reperfusion injury and damage to distant 
organs will further increase the blood level enzymes.
187ALT and AST are indicators of major alterations of liver integrity, and were utilized in 
this study as a marker of hepatocellular injury.
8.2.6 Haem Oxygenase studies
Haem oxygenase-1   (HO-1) is a ubiquitous and redox-sensitive inducible stress protein 
that degrades haem to carbon monoxide (CO), iron and biliverdin. In this study HO 
estimations were used as marker of HO production and to affirm the response to 
pharmacological manipulation with Pyrrolidine dithiocarbamate and Zinc 
Protoporphyrin. HO was measured by the bilirubin generation method as described by 
Balia et al. (Balia et al.,  1992) and is well established and of proven efficacy.
Polyclonal antibodies against the specific HO isoforms are commercially available  and 
can identify the isoforms on tissues sections and these were used for western blotting in 
this  study.  A  limitation of molecular biology techniques  is  that  they only  indicate  the 
presence  of  protein  and  as  such  may  indicate  synthesis  of  new  protein  but  these 
techniques do not give an indication of protein phosphorylation and therefore enzymatic 
activity.  The  other  option  is  to  use  enzyme  phosphorylation  assays,  but  these  are 
indirect  measurements  and  again  do  not  help  in  establishing  a  direct  link  between 
protein  and  enzymatic,  In  theory,  a  combination  of  specific  HO  isoform  genetic 
knockout model and molecular biology techniques would give a better understanding of 
HO-1  activity in a given setting.
8.2.7 Histology
188Light microscopy examination allows excellent appraisal of degree of tissue injury. In 
the ileum the end points of enterocyte necrosis, endothelial injury and neutrophil 
infiltration were chosen as histologic markers, realizing that more detailed 
ultrastructural studies may be useful either to confirm or to explain histological findings 
in some cases. In this study, clear differences were found between groups, and histology 
was of great help to understand the nature of ischaemic injury.
8.3 Overall conclusions arising from the thesis and future plans
1.  Ischaemic preconditioning was associated with an improvement in the intestinal 
microvascular perfusion, intestinal extra and intracellular oxygenation and portal venous 
blood flow.
2.  Ischaemic Preconditioning led to an improvement of red blood cell velocity (i.e. 
blood flow) and decreased the leukocyte- endothelial interactions. This protective effect 
of ischaemic preconditioning was clearly associated with an increased expression in 
haem oxygenase in the early phase of ischaemic preconditioning.
3.  The administration of HO-1 donor Pyrrolidine dithiocarbamate produced results 
similar to ischaemic preconditioning, i.e. improvement in the intestinal microvascular 
perfusion, intestinal extra and intracellular oxygenation, portal venous blood flow, 
improved red blood cell velocity and attenuated the leukocyte-endothelial interactions. 
Pyrrolidine dithiocarbamate administration was associated with increased expression of 
HO-1, whereas the administration of Zinc Protoporphyrin (HO-1  inhibitor) abolished 
this protective effect.
1894.  Ischaemic Preconditioning led to a dramatic improvement of red blood cell velocity 
(i.e. blood flow) and decreased the leukocyte- endothelial interactions as compared to 
ischaemia reperfusion. This protective effect of ischaemic preconditioning was clearly 
associated with an increased expression in HO-1.
5.  The administration of HO-1 donor Pyrrolidine dithiocarbamate produced results 
similar to ischaemic preconditioning. Pyrrolidine dithiocarbamate administration was 
associated with increased expression of HO-1, whereas the administration of Zinc 
Protoporphyrin (HO-1  inhibitor) abolished this protective effect.
6.  Ischaemia reperfusion injury of the intestine led to damage of the alveolar 
endothelium, whereas ischaemic preconditioning attenuated the pulmonary injury and 
therefore limited distant organ injury.
The above conclusions support the hypothesis presented in this study and strongly 
suggest a role for HO-1   in the protection conferred by IPC in early and late phase of 
ischaemia reperfusion induced intestinal injury.  The potential clinical application of the 
IPC effect is during small bowel transplantation. Although the technique of IPC is 
simple and easily applicable there would be concerns such as the increased operative 
time (due to period of time involving brief ischaemia and reperfusion) which may not 
be tolerated well in many operating theatres. Also other concerns such as, what is the 
ideal preconditioning time?, would IPC influence other diseased states of the intestine 
(such as post chemotherapy, shock states), these questions largely remained answered 
since critical ischaemia times for the intestine particularly with the trauma of surgery 
and disease are not known. Therefore the potential clinical application of IPC is in the 
form of targeted drug intervention. Although it may be debatable whetherpreconditioning will ever fulfill its clinical expectations, the hope that a new therapeutic 
modality may emerge from this fascinating phenomenon has given great impetus to the 
search for its underlying mechanism. Clearly, identifying the mechanism of IPC will 
allow development of pharmaceutical agents that conduct the IPC response. Such agents 
will vastly assist preservation of intestine for transplantation. The overall conclusions of 
this study suggest a central role for HO-1  in the IPC cascade. Further mechanistically 
descriptive studies would allow the development of therapeutic regimens involving HO- 
1  e.g., regime for HO donors administration prior to small bowel transplantation.
This study has shown that HO-1  is upregulated during the IPC effect. There are few 
questions which remain answered because some were not within the scope of this study. 
These questions could open avenues for future studies. Where was HO-1 expressed in 
the ileum? It would be useful to localize the expression of HO-1   in the small intestine 
by means of immunohistochemistry. It would also be useful to find out the expression 
of HO-1  at different time points starting from basal expression, before and after 
ischaemia and during reperfusion.
Finally, although current research on the mechanisms of preconditioning seems to 
diverge more and more, it is possible that all these mechanisms converge into an as yet 
unidentified final common pathway. This conclusion is based not so much on the 
negative studies and observations discussed above but on the belief that a powerful 
adaptive phenomenon that is induced so easily and reproducibly in so many models, 
laboratories, and species is almost certain to be mediated by a universal mechanism.
The data from this study suggests that haem oxygenase is the key factor in small bowel 
ischaemic preconditioning.
191Future Plans
The temporal expression of haem oxygenase-1   (HO-1) with varying time points of 
ischaemia and reperfusion will be useful if finding out at what time timepoint HO-1  is 
expressed.  It will also be informative to find out the exact localization of HO-1   in the 
ileum (which cell expresses HO-1) by means of immunohistochemistry.
These experiments were performed in warm IR injury model, this has limitations in 
small bowel transplantation model. The experimental model of cold IR injury with 
preservation will mimic small bowel transplantation.
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231Appendix 2. Protocol for Fluorescence Labelling of RBC
Stock Solution 1 (adjust to pH 7.4)
Barbital Sodium  2.55 g
1MHC1  10 ml
NaCl  6.8 g
Bring to  0.5 L
Stock Solution 2:-
MgS04.7H20  24.6 g
100ml distilled water makes  1M solution
Stock Solution 3(0.03M CaCl2):
CaCl2.2H20   4.41 g
100ml distilled water makes solution.
Note: Stock solutions can be kept for around a month in a fridge at 4°C.
Working Solution (glucose saline buffers)
Stock  1   50  ml
Stock 2  0.1  ml
Stock 3  0.1  ml
Glucose  4.2 g
Make up to 200ml with distilled water
FITC for red blood cells:-
23240mg of FITC
2ml of glucose saline buffer
Labelling cells:
1. Collect approx 8ml blood in heparinised tube or as much as you need.
2. Centrifuge blood at 400g or 2000r.p.m for lOmins
3. Remove plasma + buffy coat
4. Wash cells with glucose saline buffer 5 times
5.  1ml of washed red cells are added to 1ml of buffer and 0.4ml of FITC
6. Leave for 1.5 to 2hrs at room temp
7. Labelled cells are washed 3 times until no colouring is left in supernatant
8. Suspend in glucose saline buffer in  1:2 dilution.
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